Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R70 Cause of death: ICD-10 — R70 2 out of 7 registries used, show all original rules.	3271
4. Check minimum number of events None	3271
5. Include endpoints None	3271
6. Filter based on genotype QC (FinnGen only)	3165

Control definitions (FinnGen only)

Control exclude: R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R7
Name in latin: Ratio sedimenti erythrocytorum elevata et abnormitas viscositatis plasmatis

NAME	R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO
CONTROL_EXCLUDE	R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R70
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R70
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3165	1785	1380
Unadjusted period prevalence (%)	0.63	0.63	0.63
Median age at first event (years)	66.98	64.46	70.24

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3271: Matched controls
32710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.3

ICD-10 Finland

Polymyalgia rheumatica

7.4

308.4

492

769

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

37149.6

307.7

3226

PAW37

NOMESCO Finland

Biopsy of temporal artery

29.1

307.7

223

D64.9

ICD-10 Finland

Anaemia, unspecified

4.9

307.7

925

2433

XW000

NOMESCO Finland

Bone marrow biopsy

6.5

221.1

388

663

H02AB06

ATC

prednisolone; systemic

3.2

220.2

2109

11815

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

14.4

204.3

188

138

R50.9

ICD-10 Finland

Fever, unspecified

3.6

202.2

845

2886

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

178.5

745

2524

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

25.8

167.6

117

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.5

156.4

629

2067

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

10.8

150.1

165

160

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

140.7

680

2490

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

137.4

1574

8914

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

135.5

1924

11980

L04AX03

ATC

methotrexate; systemic

3.6

132.1

507

1606

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

131.1

1320

7012

C03CA01

ATC

furosemide; systemic

2.3

114.6

1564

9341

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.5

110.6

429

1361

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

108.4

464

1564

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

105.4

1220

6746

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.8

105.1

349

997

UJF32

NOMESCO Finland

Coloscopy

2.2

95.4

1117

6153

M04AA01

ATC

allopurinol; systemic

2.6

95.1

705

3179

M13.9

ICD-10 Finland

Arthritis, unspecified

3.4

91.4

361

1153

JN4AD

NOMESCO Finland

Body CT examination

2.8

87.8

497

1951

L04AX01

ATC

azathioprine; systemic

4.4

85.3

222

529

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

81.1

281

823

J01MA12

ATC

levofloxacin; systemic

2.3

80.3

815

4187

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

72.6

775

4045

JN4BD

NOMESCO Finland

Extensive body CT

2.5

70.4

488

2107

A02BC02

ATC

pantoprazole; systemic

2.0

69.9

2350

18222

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

65.0

147

312

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

64.3

306

1085

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.3

64.2

105

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

17.6

63.6

C90.0

ICD-10 Finland

Multiple myeloma

6.5

62.4

103

163

M31.6

ICD-10 Finland

Other giant cell arteritis

19.1

62.3

A10AC01

ATC

insulin (human); parenteral

2.7

61.9

371

1487

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

59.3

206

602

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.9

58.8

301

1110

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

58.5

473

2180

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

58.2

819

4688

P01BA02

ATC

hydroxychloroquine; oral

2.6

57.8

355

1439

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

55.8

303

1152

R70.1

ICD-10 Finland

Abnormal plasma viscosity

+∞

55.4

A10AB05

ATC

insulin aspart; parenteral

2.7

54.6

332

1337

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

6.2

53.8

154

L88

ICPC

Rheumatoid/seropositive arthritis

3.4

52.3

193

586

H02AB07

ATC

prednisone; oral

2.1

52.2

574

2990

I77.6

ICD-10 Finland

Arteritis, unspecified

15.9

51.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

50.7

665

3692

R06.0

ICD-10 Finland

Dyspnoea

1.8

50.3

1017

6501

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

50.2

791

4672

I50.0

ICD-10 Finland

Congestive heart failure

2.3

49.3

399

1833

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

49.2

885

5449

R53

ICD-10 Finland

Malaise and fatigue

1.9

49.2

878

5394

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.8

48.9

113

244

N19

ICD-10 Finland

Unspecified kidney failure

3.2

48.9

207

684

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

48.7

795

4744

M05BA04

ATC

alendronic acid; oral

2.2

48.5

445

2155

C03DA01

ATC

spironolactone; oral

2.1

48.2

532

2768

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

47.9

357

1580

A46

ICD-10 Finland

Erysipelas

2.0

47.0

586

3187

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

46.2

151

423

N02AX02

ATC

tramadol; systemic, rectal

1.7

45.2

1454

10513

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

45.2

435

2144

WW500

NOMESCO Finland

Blood transfusion

3.1

44.9

192

638

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

44.5

312

1342

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

44.1

938

6042

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

43.5

451

2286

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

43.4

350

1602

L04AA06

ATC

mycophenolic acid; systemic

5.5

43.3

159

A10AE04

ATC

insulin glargine; parenteral

2.3

43.3

375

1768

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

43.3

566

3123

TGC00

NOMESCO Finland

Bronchial lavation

3.9

43.3

129

339

ZX120

NOMESCO Finland

Intravenous

2.3

42.9

377

1789

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

42.1

435

2200

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

8.6

42.1

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

41.1

140

403

J01FF01

ATC

clindamycin; systemic

1.7

40.8

895

5794

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

10.1

40.7

M10.9

ICD-10 Finland

Gout, unspecified

2.4

39.5

298

1323

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

39.5

379

1861

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

39.3

985

6605

J01MA02

ATC

ciprofloxacin; systemic

1.6

38.9

1330

9655

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

38.8

400

2018

C07AB07

ATC

bisoprolol; oral

1.6

38.8

1779

13871

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

38.7

118

315

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

38.6

208

785

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.9

38.2

178

J01MA14

ATC

moxifloxacin; systemic

2.2

37.9

349

1685

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

37.7

256

1083

SPAT1262

SPAT

Handing over of treatment supplies

1.8

37.6

648

3896

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

37.6

184

660

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

37.4

238

976

S97

ICPC

Chronic ulcer skin

2.4

37.3

273

1195

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

37.2

601

3541

R70

ICD-10 Finland

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

371.5

37.1

SPAT1263

SPAT

Sampling

1.6

36.8

1365

10069

J01DB01

ATC

cefalexin; oral

1.7

36.8

2564

22067

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.8

36.8

117

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

36.6

255

1091

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

36.0

1230

8882

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

35.8

300

1392

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

5.9

34.9

109

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

34.8

247

E66.8

ICD-10 Finland

Other obesity

2.9

34.8

169

603

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.9

34.7

105

279

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

34.7

362

1832

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

34.2

405

2146

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.7

34.1

108

296

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.6

33.6

202

805

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.7

33.6

109

304

AA1AD

NOMESCO Finland

CT of head and brain

1.6

31.5

993

6981

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.2

31.4

204

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

31.3

812

5439

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.8

31.2

164

611

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

30.9

1005

7110

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

30.7

226

990

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

30.7

294

1438

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

30.2

522

3122

L04AA13

ATC

[U] leflunomide

3.5

29.9

105

309

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

29.8

240

1093

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.7

29.8

159

597

ZXD05

NOMESCO Finland

Urgent procedure

1.6

29.3

970

6873

T90

ICPC

Diabetes non-insulin dependent

1.6

29.1

810

5506

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

29.0

185

759

R80

ICD-10 Finland

Isolated proteinuria

6.5

29.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

28.5

160

616

N17.8

ICD-10 Finland

Other acute renal failure

4.8

28.5

139

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.7

28.3

243

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

6.2

28.0

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

27.9

167

664

A11CC03

ATC

alfacalcidol; systemic

3.3

27.9

107

333

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

27.9

414

2360

D64.8

ICD-10 Finland

Other specified anaemias

3.5

27.5

272

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

27.4

216

974

153

Kela drug reimbursment

Lenalidomid

6.4

27.3

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.8

27.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

27.2

343

1851

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

27.2

670

4408

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

27.1

151

580

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

27.0

125

435

SPAT1255

SPAT

Intravenous administration of medicine

2.1

26.9

261

1282

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

26.8

200

881

N02BE01

ATC

paracetamol; systemic, rectal

1.7

26.4

2806

25388

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

26.4

650

4270

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

26.3

1070

7899

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

26.1

356

1973

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

26.0

1049

7729

A05AA02

ATC

ursodeoxycholic acid; oral

4.5

25.9

142

B01AB05

ATC

enoxaparin; parenteral

1.5

25.9

1036

7616

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.9

1474

11653

L04AX04

ATC

lenalidomide; oral

6.2

25.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

25.7

532

3338

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

25.5

604

3928

A10AE05

ATC

insulin detemir; parenteral

2.3

25.4

195

870

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

25.4

276

1414

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

25.3

608

3966

M31.3

ICD-10 Finland

Wegener granulomatosis

9.5

25.3

TK800

NOMESCO Finland

Hemodialysis

3.5

25.1

249

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

25.1

155

626

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

25.1

118

414

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

25.1

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.0

25.0

112

382

L28

ICPC

Limited function/disability (L)

1.6

25.0

682

4589

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

25.0

201

914

AA1AA

NOMESCO Finland

Head X-ray examination

5.0

24.9

107

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

24.9

410

2409

A10BA02

ATC

metformin; oral

1.5

24.8

962

7015

A02BC01

ATC

omeprazole; systemic

1.5

24.6

920

6650

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.3

24.4

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

24.4

129

482

R03AC02

ATC

salbutamol; inhalant

1.5

24.4

1603

12977

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

24.3

210

984

I50.1

ICD-10 Finland

Left ventricular failure

2.2

24.3

218

1037

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

24.3

561

3619

SPAT1301

SPAT

No procedures

1.5

24.2

1024

7595

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.9

24.1

118

423

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

24.1

887

6387

SPAT1254

SPAT

Administration of medicine

1.7

24.0

538

3443

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

23.8

2069

17633

G47.3

ICD-10 Finland

Sleep apnoea

1.6

23.7

620

4124

C08CA01

ATC

amlodipine; oral

1.5

23.4

1323

10376

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

23.2

107

371

H02AB09

ATC

hydrocortisone; systemic

3.2

23.2

287

N02AA05

ATC

oxycodone; systemic

1.6

23.2

657

4454

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

23.1

158

670

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

23.0

278

1477

R03BB04

ATC

tiotropium bromide; inhalant

1.8

22.6

391

2326

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

22.4

1178

9089

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

22.4

193

903

A06AD11

ATC

lactulose; oral

1.6

22.4

584

3876

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.1

22.4

155

B01AA03

ATC

warfarin; systemic

1.5

22.1

773

5489

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.1

21.9

308

ZXE00

NOMESCO Finland

One hour or less

1.5

21.9

1167

9022

E0000UV, ,

ATC

1.4

21.8

1236

9661

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

21.8

151

644

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

21.7

251

1312

R02

ICPC

Shortness of breath/dyspnoea

1.7

21.6

432

2678

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.4

21.5

125

N03AX16

ATC

[U] pregabalin

1.5

21.4

727

5122

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

21.3

323

1846

A03

ICPC

Fever

1.7

21.1

413

2542

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

21.0

198

961

R60.0

ICD-10 Finland

Localized oedema

1.7

20.9

429

2677

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

6.7

20.8

A10BH05

ATC

linagliptin; oral

2.1

20.8

205

1011

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.6

20.8

108

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.3

20.8

250

N18.0

ICD-10 Finland

End-stage renal disease

4.2

20.7

133

T82

ICPC

Obesity

2.7

20.7

111

418

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

20.7

870

6406

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

20.6

109

408

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

20.3

1253

9913

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

20.2

369

2227

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

20.2

1296

10321

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.8

20.2

158

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

20.1

112

430

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.8

20.1

H02AB04

ATC

methylprednisolone; systemic

1.7

20.0

455

2913

A02BC05

ATC

esomeprazole; systemic

1.4

19.9

1208

9517

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.8

19.7

355

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.3

19.7

223

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

8.2

19.6

A10BB12

ATC

glimepiride; oral

1.8

19.6

284

1600

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

19.6

182

878

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.4

19.5

136

582

A28

ICPC

Limited function/disability NOS

1.5

19.4

667

4703

B82

ICPC

Anaemia other/unspecified

2.6

19.3

114

451

NHQ40

NOMESCO Finland

Amputation of toe

3.3

19.3

226

R77.1

ICD-10 Finland

Abnormality of globulin

46.3

19.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

19.0

890

6672

ZX108

NOMESCO Finland

Inhalation

5.7

19.0

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

18.8

R76.0

ICD-10 Finland

Raised antibody titre

+∞

18.8

WW300

NOMESCO Finland

Transfer of autologic stem cells

8.1

18.8

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

18.7

1158

9130

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

18.7

267

1498

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

18.7

164

774

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

18.6

283

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

18.8

18.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.3

1964

16965

A02BC03

ATC

lansoprazole; oral

1.4

18.3

913

6919

E000001, ,

ATC

1.5

18.2

583

4040

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

18.2

177

869

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.8

18.1

326

P01AB01

ATC

metronidazole; oral, rectal

1.4

18.1

1136

8965

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.1

18.0

246

D07AC01

ATC

betamethasone; topical

1.4

18.0

1063

8300

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.9

567

3917

J94.9

ICD-10 Finland

Pleural condition, unspecified

5.9

17.9

329

Kela drug reimbursment

Lenalidomide

6.2

17.6

N03AX12

ATC

[U] gabapentin; oral

1.6

17.5

497

3349

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

17.5

239

1320

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

17.5

319

1922

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.9

17.4

R51.80

ICD-10 Finland

Headache

1.6

17.4

412

2660

N05CF01

ATC

zopiclone; oral

1.4

17.2

1053

8257

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

17.2

828

6222

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

17.1

100

394

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

7.5

17.0

A10AB01

ATC

insulin (human); parenteral

2.5

16.8

105

427

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

16.8

189

979

J01CA04

ATC

amoxicillin; systemic

1.4

16.8

2369

21260

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.2

16.7

J01FA06

ATC

roxithromycin; oral

1.4

16.5

1176

9445

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

16.4

287

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

16.4

202

TPX00

NOMESCO Finland

Biopsy of artery or vein

23.2

16.4

C02AC05

ATC

moxonidine; oral

2.0

16.4

169

848

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.4

16.4

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.1

16.3

108

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

16.3

101

410

WZC30

NOMESCO Finland

Teaching

1.6

16.2

459

3088

A10BH01

ATC

sitagliptin; oral

1.7

16.2

322

1985

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

16.2

161

797

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

16.2

486

3315

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.0

553

3884

A07AA02

ATC

nystatin; oral

1.9

16.0

209

1138

C10AA01

ATC

simvastatin; oral

1.4

16.0

1465

12224

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

16.0

114

493

R05

ICD-10 Finland

Cough

1.5

15.9

611

4385

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

15.9

162

809

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

15.9

156

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

15.9

267

1571

WX892

NOMESCO Finland

Monitored bed care

1.8

15.8

244

1400

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

15.8

307

1881

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

15.8

231

1305

A01

ICPC

Pain general/multiple sites

1.7

15.7

292

1768

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.8

15.6

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

26.4

15.6

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.6

15.5

A04

ICPC

Weakness/tiredness general

1.5

15.5

471

3217

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

15.5

1242

10138

N06AX21

ATC

duloxetine; oral

1.7

15.5

322

2010

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.0

15.5

236

A12AA04

ATC

calcium carbonate; oral

3.2

15.5

189

C09AA02

ATC

enalapril; systemic

1.5

15.4

678

4993

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

15.4

730

5451

J01AA02

ATC

doxycycline; systemic

1.4

15.3

2352

21197

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

15.3

537

3781

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.6

15.3

136

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

14.8

15.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.0

15.3

109

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

15.3

276

Z3231

NOMESCO Finland

Registered nurse

1.4

15.3

804

6119

A10AB04

ATC

insulin lispro; parenteral

2.6

15.1

352

M46.4

ICD-10 Finland

Discitis, unspecified

6.1

15.1

M54.5

ICD-10 Finland

Low back pain

1.4

15.1

966

7599

SPAT1229

SPAT

Assessment of need for aid

1.7

15.0

287

1750

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

15.0

301

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

15.0

108

469

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.0

15.0

M10.3

ICD-10 Finland

Gout due to impairment of renal function

5.8

14.9

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.2

14.9

183

M35.1

ICD-10 Finland

Other overlap syndromes

5.5

14.8

N06AX16

ATC

venlafaxine; oral

1.6

14.8

343

2201

205

Kela drug reimbursment

Chronic hypertension

1.4

14.7

990

7841

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

14.7

302

1877

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

14.7

741

5590

R04.0

ICD-10 Finland

Epistaxis

1.7

14.7

261

1560

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

14.6

735

5542

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

14.5

523

3700

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

14.5

387

2565

R81

ICPC

Pneumonia

2.2

14.5

119

547

WX872

NOMESCO Finland

Intensive care

2.0

14.5

158

810

JN6JR

NOMESCO Finland

Extensive PET-CT of whole body metabolism (crown to foot)

36.2

14.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

14.4

311

1958

M10.0

ICD-10 Finland

Idiopathic gout

2.2

14.4

125

588

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

15.4

14.4

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

14.3

241

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

14.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

14.3

511

3611

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.9

14.3

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

14.2

196

1086

C10AA05

ATC

atorvastatin; oral

1.3

14.2

1313

10909

C09AA05

ATC

ramipril; oral

1.4

14.2

841

6518

ZY010

NOMESCO Finland

Hospital outpatient

2.2

14.2

122

572

I50

ICD-10 Finland

Heart failure

2.1

14.2

127

605

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

14.1

139

M79.6

ICD-10 Finland

Pain in limb

1.3

14.1

1167

9536

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

14.1

121

567

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

14.1

359

2356

L01BA01

ATC

methotrexate; systemic

2.2

14.0

122

574

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

14.0

393

2635

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

14.0

324

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

14.0

121

C01DA14

ATC

isosorbide mononitrate; oral

1.4

13.9

623

4598

M45

ICD-10 Finland

Ankylosing spondylitis

2.9

13.9

218

J01DA01

ATC

[U] cefalexin

1.3

13.8

1825

15937

E06.1

ICD-10 Finland

Subacute thyroiditis

5.0

13.8

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.0

13.8

197

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

13.8

388

2602

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.7

443

3063

3AC01, ,

NOMESCO Finland

3.8

13.7

109

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

13.7

595

4365

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

13.6

136

675

L17

ICPC

Foot/toe symptom/complaint

1.4

13.6

818

6349

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.3

13.6

421

M25.5

ICD-10 Finland

Pain in joint

1.4

13.5

826

6425

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.8

13.5

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.5

13.5

WW200

NOMESCO Finland

Immunization

2.6

13.5

318

B01AB10

ATC

tinzaparin; parenteral

1.6

13.5

295

1863

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

13.5

145

740

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

13.5

129

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

13.5

133

658

H3603, E103,

ICD-10 Finland

5.2

13.4

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.4

13.4

144

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.4

591

4344

A10AD05

ATC

insulin aspart; parenteral

2.5

13.3

320

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

13.3

418

L01AA01

ATC

cyclophosphamide; systemic

4.9

13.3

L01AA03

ATC

melphalan; systemic

6.3

13.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

13.2

376

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

13.2

252

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

13.2

116

549

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

13.1

125

610

D07AC13

ATC

mometasone; topical

1.4

13.1

812

6326

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

13.1

203

1167

J86.9

ICD-10 Finland

Pyothorax without fistula

3.9

13.1

L04AD01

ATC

ciclosporin; systemic

3.1

13.0

167

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.2

13.0

162

N06AA09

ATC

amitriptyline; systemic

1.6

13.0

305

1961

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

13.0

423

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.2

13.0

SPAT1310

SPAT

Counselling related to known health issue

1.4

12.9

913

7259

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

6.1

12.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

12.9

242

1468

UJD02

NOMESCO Finland

Gastroscopy

1.9

12.9

162

873

M05BA07

ATC

risedronic acid; oral

2.1

12.8

127

629

J01XX08

ATC

linezolid; systemic

4.7

12.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

12.8

223

1326

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

12.8

333

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

12.7

213

1252

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.2

12.7

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

12.7

349

2328

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

12.7

117

564

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

12.6

504

3632

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

12.6

174

965

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

12.6

153

814

E86

ICD-10 Finland

Volume depletion

2.3

12.6

441

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

12.6

311

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

12.6

108

506

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

12.6

102

467

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

12.6

175

974

N06AX11

ATC

mirtazapine; oral

1.3

12.6

959

7711

N05AH04

ATC

quetiapine; oral

1.5

12.5

441

3100

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.2

12.5

SPAT1240

SPAT

Therapeutic discussion

1.7

12.5

233

1413

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

12.4

266

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.4

866

6867

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

12.4

308

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

12.3

227

SPAT1211

SPAT

Application of soft bandage

1.6

12.3

273

1730

M10

ICD-10 Finland

Gout

1.9

12.3

145

764

K76.9

ICD-10 Finland

Liver disease, unspecified

3.3

12.3

137

P03

ICPC

Feeling depressed

1.8

12.3

201

1174

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

5.8

12.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

12.3

173

967

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

4.2

12.2

R11

ICD-10 Finland

Nausea and vomiting

1.6

12.2

263

1654

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.1

12.2

127

Kela drug reimbursment

Transplant complication

3.4

12.2

123

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.2

12.2

153

R31

ICD-10 Finland

Unspecified haematuria

1.6

12.2

326

2162

C09CA01

ATC

losartan; oral

1.4

12.1

792

6210

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

4.9

12.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.4

12.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

12.1

805

6329

WX722

NOMESCO Finland

PEEP

1.9

12.1

141

740

D07AB08

ATC

desonide; topical

1.6

12.1

300

1953

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

12.1

190

1097

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

12.1

474

3403

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

12.1

303

1979

UKC02

NOMESCO Finland

Cystoscopy

1.4

12.1

513

3740

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.6

12.0

105

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

12.0

349

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.9

12.0

192

Z2446

NOMESCO Finland

Social worker

1.8

11.9

181

1034

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.0

11.9

A10BJ02

ATC

liraglutide; parenteral

2.5

11.9

314

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.1

11.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

11.8

480

3468

A07AA09

ATC

vancomycin; oral

3.0

11.8

177

WX402

NOMESCO Finland

General anaesthesia

1.4

11.8

518

3797

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

5.9

11.8

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

11.8

225

1372

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

11.8

373

2565

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

11.7

310

2049

A41.8

ICD-10 Finland

Other specified sepsis

2.5

11.7

292

K92.1

ICD-10 Finland

Melaena

1.8

11.7

185

1070

ZXA10

NOMESCO Finland

Bilateral

1.4

11.7

570

4258

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

11.7

143

764

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

11.7

124

631

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

11.6

392

2734

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

11.5

301

N03AX09

ATC

lamotrigine; oral

2.2

11.4

466

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

11.4

414

E66

ICD-10 Finland

Obesity

2.1

11.4

112

553

M05BX04

ATC

denosumab; parenteral

1.7

11.4

213

1291

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

11.4

121

615

M79.7

ICD-10 Finland

Fibromyalgia

2.2

11.4

408

L04AA01

ATC

[U] ciclosporin

3.1

11.4

149

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.3

11.3

346

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.5

11.3

279

S18

ICPC

Laceration/cut

1.3

11.3

1327

11288

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.6

11.3

105

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.8

11.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

11.3

349

2388

T89

ICPC

Diabetes insulin dependent

2.2

11.2

437

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

11.2

457

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

25.1

11.1

PAA99

NOMESCO Finland

Exploration of other arterial branch originating from aortic arch arteries

20.1

11.1

B03XA01

ATC

erythropoietin; parenteral

3.5

11.1

111

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

11.1

222

1371

A10BJ06

ATC

semaglutide; parenteral

2.0

11.0

118

602

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

11.0

864

6951

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

11.0

408

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.0

514

3809

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

43.5

10.9

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

10.9

203

1231

RJ421, ,

NOMESCO Finland

5.4

10.9

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

10.9

133

711

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.7

10.8

220

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.9

10.8

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

10.8

411

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

10.8

229

1435

TNG10

NOMESCO Finland

Puncture of knee

3.2

10.8

128

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.8

162

924

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

10.8

111

559

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

10.7

160

910

A10BK01

ATC

dapagliflozin; oral

1.7

10.7

189

1128

5BA08, ,

NOMESCO Finland

4.4

10.7

ZX112

NOMESCO Finland

Subcutaneous

2.5

10.7

281

A10AA01, ,

ATC

2.5

10.7

269

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.5

10.6

246

D07XC01

ATC

betamethasone; topical

1.5

10.6

341

2352

C01AA05

ATC

digoxin; systemic

1.5

10.6

327

2237

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

4.2

10.5

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.2

10.5

H15.1

ICD-10 Finland

Episcleritis

3.2

10.5

130

B80

ICPC

Iron deficiency anaemia

2.3

10.5

332

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.3

10.5

115

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

10.5

410

K86.2

ICD-10 Finland

Cyst of pancreas

3.2

10.4

121

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.8

10.4

185

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

10.4

392

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

10.3

1063

8860

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

10.3

180

1072

M79.1

ICD-10 Finland

Myalgia

1.5

10.3

356

2492

R06AE07

ATC

cetirizine; oral

1.3

10.3

1142

9614

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

10.2

255

1663

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.2

719

5686

R4190

NOMESCO Finland

Nutritional therapy

2.2

10.1

409

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.9

10.1

160

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.0

10.1

114

593

D72.1

ICD-10 Finland

Eosinophilia

5.3

10.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.1

976

8065

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.6

10.1

A29

ICPC

General symptom/complaint other

1.5

10.1

375

2662

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

10.1

251

1637

A12BA01

ATC

potassium chloride; oral

1.7

10.0

179

1072

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

10.0

1033

8609

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

10.0

428

3120

J01CF05

ATC

flucloxacillin; systemic

1.8

10.0

158

916

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

9.9

361

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

4.3

9.8

K72.9

ICD-10 Finland

Hepatic failure, unspecified

4.3

9.8

A10AE06

ATC

insulin degludec; parenteral

2.1

9.8

401

C09BA02

ATC

enalapril and diuretics; systemic

1.6

9.8

263

1743

J05AB01

ATC

aciclovir; systemic

1.4

9.8

593

4577

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

9.8

343

H3601, E103,

ICD-10 Finland

4.5

9.8

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

9.8

398

2874

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

9.8

179

1081

SPAT1312

SPAT

General health counselling

1.3

9.7

855

6970

A07EA06

ATC

budesonide; oral, local oral

2.1

9.7

443

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.8

9.7

175

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

9.7

167

991

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.1

9.7

450

C07AB02

ATC

metoprolol; systemic

1.3

9.7

691

5470

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.9

9.6

148

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.6

672

5299

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

9.6

138

776

B01AF02

ATC

apixaban; oral

1.4

9.6

426

3121

OAB50, ,

SPAT

1.8

9.6

150

865

RJ410, ,

NOMESCO Finland

5.3

9.6

SPAT1260

SPAT

Consultation of another employee

1.4

9.6

500

3766

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

9.6

252

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

9.6

418

B01AC04

ATC

clopidogrel; oral

1.4

9.6

537

4094

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.6

500

3768

R42

ICD-10 Finland

Dizziness and giddiness

1.3

9.6

700

5558

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.6

819

6648

AN1

Coronary angiography

1.4

9.6

371

2654

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.9

9.5

149

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.5

374

2683

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.5

9.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

9.4

189

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.8

9.4

161

R77.0

ICD-10 Finland

Abnormality of albumin

100.3

9.4

SPAT1139

SPAT

Nutrition survey

1.9

9.4

111

587

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.4

212

1351

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

9.4

429

S01

ICPC

Pain/tenderness of skin

1.8

9.4

128

710

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

9.3

988

8242

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.5

9.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

9.3

225

1456

JN6AD

NOMESCO Finland

CT of torso and neck

2.6

9.3

196

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

9.3

148

859

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

4.5

9.3

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.2

9.3

364

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.4

9.3

244

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.9

9.3

146

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

9.3

112

597

R55

ICD-10 Finland

Syncope and collapse

1.5

9.2

349

2484

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

9.2

1117

9472

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

9.2

208

1325

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.2

9.2

353

J01EA01

ATC

trimethoprim; systemic

1.3

9.2

787

6387

A01AB09

ATC

miconazole; local oral

1.5

9.2

265

1787

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

9.1

313

2185

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

9.1

169

1023

207

Kela drug reimbursment

Chronic arrhythmias

1.4

9.1

538

4135

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.8

9.0

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.4

9.0

K08.3

ICD-10 Finland

Retained dental root

1.6

9.0

207

1324

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

9.0

143

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

9.0

154

C08CA13

ATC

lercanidipine; oral

1.4

9.0

446

3332

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

9.0

206

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.1

9.0

376

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

8.9

201

1279

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

8.9

108

576

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

8.9

170

1038

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.3

8.9

102

V03AE01

ATC

polystyrene sulfonate; oral

2.7

8.9

178

M31.7

ICD-10 Finland

Microscopic polyangiitis

12.6

8.9

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

8.8

459

S20

ICPC

Corn/callosity

2.2

8.8

319

V03AE02

ATC

sevelamer; oral

4.7

8.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

8.8

262

1777

L03

ICPC

Low back symptom/complaint

1.3

8.8

711

5717

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.8

561

4363

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.7

207

1335

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.7

8.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.8

8.7

146

K77

ICPC

Heart failure

2.1

8.7

388

RJ411, ,

NOMESCO Finland

4.3

8.7

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

8.6

100

526

E83.50

ICD-10 Finland

Hypercalcemia

2.7

8.6

169

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.7

8.6

158

H25.8

ICD-10 Finland

Other senile cataract

1.4

8.6

403

2981

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.0

8.6

TAB00

NOMESCO Finland

Lumbar puncture

1.9

8.6

109

591

SPAT1325

SPAT

Vaccination

1.3

8.6

1017

8586

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.6

729

5901

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

8.6

330

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

8.6

219

1437

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

8.6

138

805

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

8.5

112

614

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

10.0

8.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

8.5

108

586

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

8.5

267

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

8.5

351

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.8

8.5

148

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

8.5

105

565

J04AB02

ATC

rifampicin; systemic

2.7

8.5

165

WVA20

NOMESCO Finland

Medicine administration

2.2

8.5

325

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.7

8.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.7

8.4

SPAT1216

SPAT

Assessment of functional ability

1.3

8.4

518

4003

N06AX12

ATC

bupropion; oral

1.8

8.4

116

646

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

8.4

656

5247

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

8.4

203

1315

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

8.4

475

N05AA02

ATC

levomepromazine; systemic

1.9

8.4

104

560

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.8

8.4

149

P01

ICPC

Feeling anxious/nervous/tense

1.6

8.4

208

1356

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

8.3

175

1096

WX882

NOMESCO Finland

High dependency care

2.1

8.3

394

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

8.3

194

1246

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.0

8.3

117

NGU00

NOMESCO Finland

Removal of partial prosthesis from knee joint, other or unspecified

8.5

8.3

R50.1

ICD-10 Finland

Persistent fever

10.8

8.3

318

Kela drug reimbursment

Teriparatide

3.6

8.3

J20

ICD-10 Finland

Acute bronchitis

1.5

8.2

257

1761

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

8.2

152

921

A07EC02

ATC

mesalazine; oral, rectal

1.8

8.2

129

747

A10AA02, ,

ATC

1.9

8.2

493

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

8.2

376

K55.2

ICD-10 Finland

Angiodysplasia of colon

3.4

8.2

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

8.2

297

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.2

228

1525

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

8.2

289

2031

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.9

8.1

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

8.1

210

R03AC13

ATC

formoterol; inhalant

1.7

8.1

150

909

RJ420, ,

NOMESCO Finland

4.5

8.1

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.8

8.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

8.1

412

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.1

287

2018

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.2

8.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

8.1

220

1465

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.0

8.1

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.8

8.1

141

V03AE03

ATC

lanthanum carbonate; oral

6.8

8.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

8.0

127

737

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

8.0

511

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

8.0

497

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

8.0

222

1484

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

8.0

194

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.1

8.0

104

J45.8

ICD-10 Finland

Mixed asthma

1.9

8.0

477

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

8.0

401

A49

ICD-10 Finland

Bacterial infection of unspecified site

4.3

7.9

D02AE01

ATC

carbamide; topical

1.6

7.9

168

1055

R03BA05

ATC

fluticasone; inhalant

1.4

7.9

467

3585

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

7.9

129

756

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

6.6

7.9

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.6

7.9

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

7.8

283

ZXA00

NOMESCO Finland

Right side

1.3

7.8

786

6492

D05AX52

ATC

calcipotriol, combinations; topical

1.7

7.8

131

774

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

7.8

488

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

7.8

140

843

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

7.8

140

843

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.9

7.8

524

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.0

7.8

111

L04AB04

ATC

adalimumab; parenteral

2.5

7.7

197

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.7

7.7

G44.2

ICD-10 Finland

Tension-type headache

1.4

7.7

325

2359

E87.6

ICD-10 Finland

Hypokalaemia

1.8

7.7

101

554

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

7.7

133

792

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.9

7.7

117

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

7.7

109

613

N30.0

ICD-10 Finland

Acute cystitis

1.3

7.7

463

3565

C08CA05

ATC

nifedipine; systemic

1.6

7.7

196

1287

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.7

7.7

145

ZXA05

NOMESCO Finland

Left side

1.3

7.7

729

5978

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.5

7.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

7.6

222

1500

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.6

7.6

157

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.0

7.6

107

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

7.6

271

1907

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.0

7.6

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.1

7.6

102

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.6

7.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

7.6

153

950

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

7.5

152

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

7.5

164

1037

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.6

7.5

164

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.2

7.5

269

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

7.5

104

581

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

7.5

184

1197

WX723

NOMESCO Finland

CPAP therapy

1.9

7.5

466

K59.0

ICD-10 Finland

Constipation

1.6

7.5

169

1078

I20.09

ICD-10 Finland

Unstable angina

1.6

7.5

187

1222

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

7.4

172

1104

J01FA09

ATC

clarithromycin; systemic

1.3

7.4

757

6257

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.4

7.4

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

7.4

484

3770

212

Kela drug reimbursment

Gout

2.1

7.4

350

XG405

NOMESCO Finland

Education on PEF monitoring

2.5

7.4

177

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.0

7.4

357

N06AB04

ATC

citalopram; systemic

1.3

7.4

561

4463

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

7.4

108

613

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.4

537

4247

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

7.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.0

7.4

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

6.0

7.4

160

Kela drug reimbursment

exenatide

2.3

7.3

246

P76

ICPC

Depressive disorder

1.7

7.3

125

742

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

7.3

520

R50.0

ICD-10 Finland

Fever with chills

8.4

7.3

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.9

7.3

435

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.3

519

4092

SPAT1104

SPAT

Monitoring of emergency patient

1.6

7.3

185

1213

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.3

568

4535

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

7.3

279

D07AA02

ATC

hydrocortisone; topical

1.4

7.3

336

2478

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

7.3

373

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

7.3

247

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.3

7.3

228

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

7.3

924

7836

M01AH01

ATC

celecoxib; oral

1.3

7.2

497

3898

NGQ20

NOMESCO Finland

Amputation of lower leg

3.4

7.2

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

7.2

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

7.2

160

1016

A08

ICPC

Swelling

1.6

7.2

155

977

C03AA03

ATC

hydrochlorothiazide; oral

1.4

7.2

298

2156

NFQ20

NOMESCO Finland

Amputation of femur

2.9

7.2

116

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

7.2

118

693

L04AK01

ATC

leflunomide; oral

3.9

7.2

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.1

7.2

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.2

326

2399

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.1

1401

12433

H05AA02

ATC

teriparatide; parenteral

3.6

7.1

E000006, ,

ATC

1.5

7.1

185

1220

EBA00

NOMESCO Finland

Extraction of tooth

1.3

7.1

874

7380

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.3

7.1

224

L95.8

ICD-10 Finland

Other vasculitis limited to skin

6.6

7.1

B34

ICPC

Blood and Immunity, Blood test

7.9

7.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.1

125

749

C09CA03

ATC

valsartan; oral

1.4

7.1

264

1874

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

7.1

329

M25.9

ICD-10 Finland

Joint disorder, unspecified

3.0

7.1

101

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

7.1

512

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

7.0

158

1007

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

7.0

225

M05BA06

ATC

ibandronic acid; systemic

2.0

7.0

364

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

7.0

155

984

L03AA02

ATC

filgrastim; parenteral

1.9

7.0

441

A04AA01

ATC

ondansetron; systemic, rectal

1.5

7.0

212

1444

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

7.0

I95.9

ICD-10 Finland

Hypotension, unspecified

2.2

7.0

251

H57.1

ICD-10 Finland

Ocular pain

1.9

7.0

456

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.5

7.0

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

7.0

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.0

202

1364

D09AB01

ATC

zinc bandage without supplements; topical

2.1

6.9

278

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.9

249

1756

N06AB10

ATC

escitalopram; oral

1.3

6.9

445

3458

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

6.9

304

2224

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

6.9

1352

11983

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

6.9

Z00.0

ICD-10 Finland

General medical examination

1.3

6.9

514

4077

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

6.9

175

1148

N05BA01

ATC

diazepam; systemic, rectal

1.4

6.9

357

2683

Z00.8

ICD-10 Finland

Other general examinations

1.5

6.9

185

1229

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.5

6.9

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

6.9

480

A10BJ05

ATC

dulaglutide; parenteral

2.3

6.9

221

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

6.9

356

2676

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.5

6.8

166

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.8

6.8

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

3.8

6.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

6.8

163

1056

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.8

196

1323

F34.1

ICD-10 Finland

Dysthymia

1.9

6.8

411

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

6.8

121

728

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

9.3

6.8

N06AB03

ATC

fluoxetine; oral

1.4

6.8

299

2189

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.3

6.7

J01DC02

ATC

cefuroxime; systemic

1.7

6.7

122

737

WX213

NOMESCO Finland

Lower leg blockade

3.1

6.7

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

6.7

236

J01FA10

ATC

azithromycin; systemic

1.2

6.7

1400

12475

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.4

6.7

192

J01DA09

ATC

[U] cefadroxil

1.3

6.7

679

5601

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.0

6.7

350

R13

ICD-10 Finland

Dysphagia

1.5

6.7

197

1335

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

6.7

121

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

6.7

357

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

6.7

134

831

J05AB11

ATC

valaciclovir; oral

1.4

6.7

362

2740

M01AE02

ATC

naproxen; oral, rectal

1.2

6.7

1477

13233

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.5

6.7

156

Z3226

NOMESCO Finland

Physiotherapist

1.3

6.7

488

3861

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

6.7

616

5025

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

6.6

522

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.8

6.6

103

596

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

6.6

122

740

TK810

NOMESCO Finland

Hemofiltration

3.7

6.6

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

6.4

6.6

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

6.6

148

943

M13.8

ICD-10 Finland

Other specified arthritis

2.9

6.6

105

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

6.6

187

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

6.6

102

590

N02BF01

ATC

gabapentin; oral

1.5

6.6

199

1356

A10BB01

ATC

glibenclamide; oral

1.6

6.6

153

984

R77.8

ICD-10 Finland

Other specified abnormalities of plasma proteins

12.3

6.6

L04AD02

ATC

tacrolimus; systemic

3.5

6.6

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.4

6.5

188

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.3

6.5

L04AA11

ATC

[U] etanercept

4.2

6.5

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.2

6.5

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.0

6.5

R10.0

ICD-10 Finland

Acute abdomen

1.9

6.5

438

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.4

6.5

176

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.5

145

923

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

6.5

382

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

6.5

195

1328

N05BA04

ATC

oxazepam; oral

1.3

6.5

723

6029

C08CA02

ATC

felodipine; oral

1.4

6.5

301

2223

J46

ICD-10 Finland

Status asthmaticus

1.9

6.5

425

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.2

6.5

J47

ICD-10 Finland

Bronchiectasis

2.1

6.5

300

NG1DA

NOMESCO Finland

X-ray of knees

2.1

6.4

260

RD210, ,

NOMESCO Finland

2.4

6.4

177

TPX15

NOMESCO Finland

Removal of vascular injection port

3.9

6.4

XKD00

NOMESCO Finland

Uroflowmetry

1.3

6.4

415

3226

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.2

6.4

SPAT1088

SPAT

Blood transfusion

3.4

6.4

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

6.4

209

1447

L16

ICPC

Ankle symptom/complaint

1.4

6.4

272

1978

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

6.4

226

1591

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.6

6.4

142

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

6.4

137

866

N02BF02

ATC

pregabalin; oral

1.6

6.3

139

883

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.8

6.3

108

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.9

6.3

393

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

6.3

390

3013

J98.1

ICD-10 Finland

Pulmonary collapse

3.2

6.3

T78.3

ICD-10 Finland

Angioneurotic oedema

2.4

6.3

161

D11

ICPC

Diarrhoea

1.4

6.3

254

1832

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

6.3

149

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

6.3

311

2322

D68.8

ICD-10 Finland

Other specified coagulation defects

3.0

6.3

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

3.0

6.3

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

6.3

380

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

6.2

106

630

R04.2

ICD-10 Finland

Haemoptysis

1.7

6.2

104

615

S76

ICPC

Skin infection other

1.6

6.2

140

894

XF402

NOMESCO Finland

ECG with work load test

1.4

6.2

294

2178

M54

ICD-10 Finland

Dorsalgia

1.4

6.2

277

2032

SPAT1153

SPAT

Removal of sutures

1.2

6.2

891

7634

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

6.2

298

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.5

6.2

144

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

6.2

172

1153

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.0

6.2

319

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

2.3

6.2

187

R52.9

ICD-10 Finland

Pain, unspecified

1.4

6.2

241

1727

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

6.2

245

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.0

6.2

SPAT1097

SPAT

Recording of ECG

1.3

6.1

422

3308

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.7

6.1

121

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.3

6.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.1

210

1468

E000003, ,

ATC

1.7

6.1

104

618

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.3

6.1

XF640, ,

NOMESCO Finland

1.8

6.1

484

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

6.1

194

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.4

6.1

157

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

3.8

6.1

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.7

6.1

116

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

12.5

6.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

6.1

504

4052

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.5

6.1

186

1272

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

6.1

227

K29.6

ICD-10 Finland

Other gastritis

2.3

6.1

176

K07

ICPC

Swollen ankles/oedema

1.6

6.1

148

964

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.8

6.0

105

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.1

6.0

WX720

NOMESCO Finland

Own respiration

1.7

6.0

113

690

WW400

NOMESCO Finland

Plasmaferesis

10.0

6.0

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

10.0

6.0

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.7

6.0

110

667

H65.2

ICD-10 Finland

Chronic serous otitis media

2.5

6.0

140

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

3.2

6.0

Z49.2

ICD-10 Finland

Other dialysis

3.2

6.0

N07BB01

ATC

disulfiram; oral

1.9

6.0

407

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

454

641

8.06

311.73

1.9

1.4

0.25

0.24

g/l

1.14

429

614

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

577

1055

6.43

310.81

3.3

2.2

11.96

10.16

g/l

9.67

515

923

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

810

892

11.74

307.65

3.2

38.39

49.76

mg/l

0.85

596

736

(3004588) Protein electrophoresis panel - Serum or Plasma

1235

1989

9.37

307.65

3.2

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

800

1323

7.68

307.65

3.2

1.8

2.39

1.45

g/l

4.79

732

1187

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

644

1125

6.88

307.65

3.2

2.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

763

1021

9.44

307.65

1.6

1.5

8.45

24.37

u/ml

0.94

(3037756) Immunofixation for Serum or Plasma

579

593

11.65

307.65

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

691

665

12.91

307.65

2.9

3.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

810

894

11.71

307.65

3.2

3.1

52.67

115.73

mg/l

0.50

594

734

(3037522) Nuclear Ab [Titer] in Serum

1210

2976

5.87

307.65

1.5

1.3

570.18

526.67

titre

0.32

326

660

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

644

1126

6.88

307.65

3.2

2.2

8.35

7.45

g/l

23.80

586

1001

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

380

393

10.81

307.65

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

643

1123

6.88

307.65

3.2

2.2

4.17

3.63

g/l

9.57

583

1000

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1077

3209

4.51

307.65

3.9

3.8

226.55

246.18

u/l

4.01

1006

3002

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

576

789

8.65

307.65

1.9

1.6

393.53

221.58

titre

0.63

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

595

1042

6.76

307.65

3.4

2.3

3.17

3.01

g/l

2.15

537

918

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

797

867

11.83

307.65

3.1

1.87

1.76

ratio

0.10

(3005719) IgG [Mass/volume] in Serum or Plasma

879

1698

6.71

307.65

3.7

2.6

12.00

10.47

g/l

8.50

814

1536

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

576

992

6.83

307.65

1.7

1.8

36.53

38.25

u/l

0.98

503

861

(3020630) Protein [Mass/volume] in Serum or Plasma

1264

2391

7.99

307.65

3.5

2.5

68.92

66.06

g/l

22.73

1156

2145

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

456

663

7.83

304.98

1.9

1.4

1.30

1.17

g/l

9.66

429

635

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

386

465

9.28

301.92

1.4

1.2

146.67

290.91

titre

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

499

838

6.85

291.68

1.3

1.2

0.25

0.70

u/ml

0.89

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

527

942

6.48

289.60

3.7

2.3

1.94

1.00

g/l

2.65

437

799

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

419

608

7.76

280.06

1.7

1.9

11.80

12.08

mg/l

0.17

378

551

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

430

676

7.17

266.87

1.6

1.5

0.32

1.07

iu/ml

0.38

155

(40760892) CBC W Ordered Manual Differential panel - Blood

2206

11895

3.62

263.02

11.6

6.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1060

3726

3.73

248.51

3.4

2.5

18.88

21.94

10.70

903

3118

(3022948) Iron [Moles/volume] in Serum or Plasma

1153

4301

3.60

246.49

3.4

2.4

10.23

12.40

umol/l

24.32

1079

3957

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1098

3974

3.65

245.87

3.3

2.4

2.17

2.29

g/l

8.49

1022

3631

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

394

636

6.91

237.75

1.7

1.5

11.91

20.63

iu/ml

0.57

(3001604) Monocytes [#/volume] in Blood

2237

12668

3.42

235.46

10.1

5.4

0.65

0.60

e9/l

15.28

2063

10815

(3006315) Basophils [#/volume] in Blood

2241

12714

3.42

234.95

10.1

5.4

0.04

e9/l

1.09

2071

10851

(3027945) Reticulocytes/100 erythrocytes in Blood

975

3365

3.70

233.17

2.8

2.4

1.81

1.80

0.10

863

2925

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

441

818

6.08

231.51

3.2

2.1

0.08

0.03

g/l

0.82

389

743

(3013115) Eosinophils [#/volume] in Blood

2274

13159

3.39

227.51

10.4

5.6

0.19

e9/l

0.04

2116

11367

(3019198) Lymphocytes [#/volume] in Blood

2252

12999

3.35

225.37

10.3

5.5

1.79

1.89

e9/l

2.08

2101

11351

(3022096) Basophils/100 leukocytes in Blood

2094

11607

3.23

224.29

10.6

5.7

0.63

0.66

1.89

1999

10708

(3019069) Monocytes/100 leukocytes in Blood

2136

12014

3.24

222.27

11.3

6.0

8.73

8.75

0.09

2035

11112

(3006504) Eosinophils/100 leukocytes in Blood

2124

11965

3.21

219.26

10.7

5.7

2.59

2.82

5.27

2028

11053

(3023520) Reticulocytes [#/volume] in Blood

799

2530

3.86

215.45

3.2

2.4

68.61

68.57

e9/l

0.01

634

1917

(3002030) Lymphocytes/100 leukocytes in Blood

2148

12274

3.18

214.31

11.0

5.8

24.44

26.83

21.10

2046

11384

(3018010) Neutrophils/100 leukocytes in Blood

2113

12088

3.11

207.86

10.4

5.6

60.98

58.01

25.13

2015

11202

(3007164) IgA [Mass/volume] in Serum or Plasma

1087

4342

3.25

201.98

2.3

1.4

3.29

2.53

g/l

11.37

829

2448

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1023

3976

3.29

198.54

1.4

1.3

47.15

37.79

iu/ml

0.70

358

1245

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

425

876

5.43

198.07

3.2

2.1

35.65

37.47

g/l

6.40

365

752

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

372

693

5.93

193.39

2.1

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

984

3790

3.28

193.18

1.4

1.2

13.64

14.81

u/ml

0.15

335

1366

(3017704) Immunofixation for Urine

184

149

13.03

188.55

1.5

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

235

277

9.06

185.47

1.8

1.9

—

(3044927) Protein electrophoresis panel - Urine

246

310

8.50

183.99

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

380

767

5.47

180.79

3.4

2.1

0.00

g/l

0.50

330

697

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

518

1361

4.33

178.88

1.7

2.01

1.53

g/l

15.09

435

1165

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

375

756

5.47

178.59

3.4

2.2

0.00

g/l

-0.00

326

696

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1462

7278

2.82

178.19

3.1

2.2

3.13

3.07

mg/l

0.50

1307

6108

(3013650) Neutrophils [#/volume] in Blood by Automated count

2333

14852

2.99

175.18

13.6

8.6

4.70

4.19

e9/l

21.15

2161

12869

(3024980) IgG subclass 4 [Mass/volume] in Serum

234

311

8.03

167.19

1.7

1.6

0.85

0.78

g/l

0.35

160

233

(3003458) Phosphate [Moles/volume] in Serum or Plasma

888

3576

3.04

157.43

7.3

5.2

1.08

1.04

mmol/l

4.11

830

3281

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

451

1180

4.27

155.66

2.4

1.9

1.25

2.09

ug/l

1.12

385

1007

(3017181) Myelocytes/100 leukocytes in Blood

648

2188

3.45

154.25

5.8

3.8

0.84

0.90

0.27

287

774

(3024561) Albumin [Mass/volume] in Serum or Plasma

1967

11946

2.62

153.12

6.9

4.6

32.92

34.88

g/l

42.65

1836

10993

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2194

14049

2.71

153.06

11.2

6.5

1.21

mmol/l

1.32

1787

11817

(3026493) Urate [Moles/volume] in Serum or Plasma

1342

6828

2.64

150.69

3.6

2.7

2038.70

5844.51

umol/l

4.01

1180

5834

(3002179) Metamyelocytes/100 leukocytes in Blood

598

1992

3.45

144.80

5.6

3.7

0.51

0.70

1.56

248

669

(4062490) Immunoglobulin typing, IgG

174

193

9.47

143.55

1.7

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

172

192

9.40

141.20

1.6

1.4

8.09

6.99

g/l

1.28

110

131

(3024139) IgG subclass 3 [Mass/volume] in Serum

172

192

9.40

141.20

1.6

1.4

0.48

0.41

g/l

0.85

112

131

(3028192) IgG subclass 2 [Mass/volume] in Serum

172

192

9.40

141.20

1.6

1.4

3.31

2.96

g/l

0.93

111

132

(3021440) Promyelocytes/100 leukocytes in Blood

608

2082

3.36

140.57

6.0

3.8

0.07

0.10

0.69

243

674

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1789

10755

2.46

136.58

4.5

2.8

211.64

134.44

ug/l

11.56

1664

9739

(3025159) Blasts/100 leukocytes in Blood

575

1954

3.36

134.19

6.1

3.9

0.18

0.26

0.18

205

554

(46235355) HIV 1 and 2 tests - Meaningful Use set

758

3038

2.95

133.10

1.7

—

(3023368) Bacteria identified in Blood by Culture

1443

7990

2.44

130.66

6.7

4.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1978

12765

2.39

124.08

9.1

5.7

1.21

mmol/l

0.00

1851

11484

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2097

13935

2.41

122.19

7.8

5.9

9.72

11.79

umol/l

19.41

2005

13149

(3042111) Morphology [Interpretation] in Bone marrow Narrative

243

468

5.53

120.73

1.4

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

604

2257

3.06

119.13

2.4

2.1

343.81

374.62

nmol/l

3.45

554

2043

(3020876) Protein [Mass/time] in 24 hour Urine

180

287

6.58

108.50

2.5

2.2

1.13

1.38

g/24h

0.33

140

(3017143) Hepatitis C virus Ab [Presence] in Serum

567

2161

2.96

107.16

1.6

1.5

—

(3018418) pH of Serum or Plasma

1420

8346

2.24

105.83

6.5

3.8

7.40

0.12

391

1582

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

257

593

4.62

103.13

1.4

1.2

13.44

3.90

u/ml

0.64

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

259

603

4.58

102.77

1.4

1.2

11.92

7.96

u/ml

0.37

100

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

232

494

4.98

102.60

1.3

1.2

1.52

4.76

u/ml

0.84

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

148

204

7.55

101.99

1.7

1.9

3.54

4.42

mg/l

1.96

139

196

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

335

955

3.79

101.12

3.2

2.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

286

730

4.20

100.70

1.7

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

265

640

4.42

100.32

1.4

1.2

35.80

40.91

u/ml

0.09

(3020779) Urea [Moles/volume] in Serum or Plasma

606

2477

2.78

100.02

9.3

6.4

12.04

10.67

mmol/l

3.95

581

2332

(3019309) Folate [Moles/volume] in Red Blood Cells

1097

5920

2.28

99.25

2.2

1.8

1270.03

1167.89

nmol/l

2.43

856

4384

(3013707) Erythrocyte sedimentation rate by Westergren method

2544

19223

2.46

98.86

10.8

4.1

37.03

13.60

mm/h

271.01

2402

17536

(3037121) Protein [Mass/volume] in Urine

335

974

3.72

98.16

2.7

2.9

0.32

0.29

g/l

0.29

175

357

(3007566) Smooth muscle Ab [Titer] in Serum

235

529

4.71

97.13

1.1

144.33

90.31

titre

0.58

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1410

8477

2.17

96.99

2.6

2.1

158.02

212.86

u/l

1.80

1328

7873

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1387

8297

2.17

96.52

3.1

2.5

54.48

69.21

u/l

0.87

1293

7589

(3042936) Bacteria identified in Isolate by Culture

790

3785

2.43

93.25

2.6

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

204

429

5.01

91.42

4.4

4.8

151.16

718.20

iu/ml

0.97

(3000012) Reticulocyte production index

202

424

5.01

90.71

2.8

2.0

—

(3026782) Osmolality of Urine

1024

5558

2.23

89.71

3.7

2.9

494.60

531.22

mosm/kgh2o

7.22

911

4729

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1676

11003

2.07

88.88

3.0

2.2

79.42

79.21

nmol/l

0.10

1524

9609

(3034770) Mitochondria Ab [Titer] in Serum

226

537

4.45

87.17

1.2

821.82

1406.25

titre

0.57

(3021960) Folate [Moles/volume] in Serum or Plasma

1184

6868

2.13

87.09

1.9

1.6

19.44

20.64

nmol/l

1.76

1061

5754

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

597

2630

2.55

83.58

1.7

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2587

20273

2.32

82.83

13.2

7.3

86.42

79.68

u/l

9.56

2496

18892

(3000850) Epithelial cells [#/volume] in Urine

1030

5777

2.14

81.68

3.5

2.6

5.90

5.76

e6/l

0.10

956

5157

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

498

2051

2.68

79.74

2.0

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

839

4390

2.23

78.90

3.3

3.0

0.81

0.82

mmol/l

1.53

783

4048

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

167

336

5.18

78.65

2.6

2.5

557.65

1345.21

u/ml

0.53

(3037467) Urinalysis macro (dipstick) panel - Urine

2374

18249

2.10

75.60

7.3

4.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

892

4858

2.15

75.33

2.5

1.8

—

(3047189) Immunofixation for 24 hour Urine

100

127

8.09

73.81

1.7

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

514

2255

2.52

71.80

4.8

3.5

98.80

92.31

ng/l

0.71

443

1885

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

389

4.64

71.36

1.4

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

144

277

5.39

71.28

1.3

1.2

46.83

52.58

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

13.73

70.80

1.3

44.80

142.25

titre

—

(3002582) Erythrocytes [#/volume] in Urine

1281

8167

1.93

68.37

4.4

3.2

53.90

89.83

e6/l

1.13

1108

6288

(3022217) INR in Platelet poor plasma by Coagulation assay

1859

13386

1.90

68.14

22.1

17.9

1.30

1.35

inr

1.50

646

3813

(3021879) Hepatitis B virus core Ab [Presence] in Serum

362

1373

2.84

67.41

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

168

391

4.48

66.34

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

160

360

4.62

65.91

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

180

448

4.19

65.14

1.3

1.2

48.30

42.94

u/ml

0.16

(3030467) Casts [#/volume] in Urine by Automated count

1189

7490

1.92

65.01

4.3

3.2

0.38

0.53

e6/l

2.01

1037

5729

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

221

642

3.62

64.27

2.1

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

191

503

3.97

64.00

4.5

3.4

60.63

58.05

1.73

191

503

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

517

2391

2.38

63.82

5.7

3.7

1.22

1.23

mmol/l

0.90

476

2056

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1212

7794

1.88

61.36

3.8

3.0

35.77

37.67

u/l

0.23

1140

7374

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1661

11791

1.83

61.05

2.5

2.1

94.12

94.03

pmol/l

0.02

966

5949

(36304419) Bacteria [Presence] in Urine

1142

7232

1.89

60.44

4.3

3.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1342

8959

1.84

59.95

3.9

3.1

2370.88

1704.47

ng/l

3.25

1170

7728

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

209

614

3.57

59.70

2.1

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1398

9473

1.83

59.31

5.2

3.7

89.39

124.75

e6/l

0.82

1160

6726

(3015377) Calcium [Moles/volume] in Serum or Plasma

1403

9532

1.83

58.89

3.7

3.4

2.34

2.35

mmol/l

4.32

1230

8169

(3013826) Glucose [Moles/volume] in Serum or Plasma

2073

15862

1.84

58.39

7.3

4.6

7.01

6.78

mmol/l

4.79

1971

14880

(3048879) Bone marrow aspiration report

8.85

57.42

1.7

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

144

334

4.46

57.06

1.3

1.2

315.21

269.21

u/ml

0.91

197

(3048929) Epstein Barr virus Ab [Presence] in Serum

185

516

3.74

57.06

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

520

2552

2.23

55.26

2.4

2.1

0.19

0.21

g/l

2.70

475

2363

(3021589) Normoblasts [#/volume] in Blood

1563

11109

1.78

55.23

19.4

9.8

0.00

e9/l

1.01

1360

8993

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

143

343

4.31

54.27

1.4

114.31

124.15

u/ml

0.32

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

200

608

3.44

54.14

1.7

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

410

1838

2.41

53.75

5.2

3.6

5.17

5.16

kpa

0.14

392

1722

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

118

245

4.96

53.50

1.3

1.2

57.51

63.04

u/l

0.33

110

219

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

432

3.89

53.26

1.9

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

140

338

4.28

52.68

1.8

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

169

471

3.73

52.15

2.0

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

228

770

3.11

51.94

1.9

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1721

12741

1.74

51.30

5.8

4.0

0.00

estimate

0.21

534

2596

(21494434) Karyotype in Bone marrow

113

235

4.94

51.13

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

528

2684

2.15

51.09

2.2

2.1

184.26

153.42

ug/g

0.65

422

2070

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

366

4.07

50.59

1.8

1.5

—

(3009343) pH of Capillary blood

399

1816

2.36

50.40

5.2

3.6

7.41

0.11

232

(3031040) Bacteria [#/volume] in Urine by Automated count

2234

17855

1.79

50.38

6.9

4.9

501.54

2519.93

e6/l

2.72

278

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

199

637

3.26

49.56

3.1

2.9

1.84

1.63

mg/l

2.21

179

564

(3009261) Glucose [Presence] in Urine by Test strip

1728

12894

1.72

49.28

5.8

4.0

0.00

estimate

1.08

491

2342

(3007853) Bacteria identified in Skin by Aerobe culture

579

3090

2.06

49.12

2.3

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

146

383

3.94

49.10

1.9

1.4

—

(3045142) Bone marrow Pathology biopsy report

124

290

4.40

48.60

1.2

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

384

1751

2.35

48.20

5.2

3.6

1.95

mmol/l

0.00

295

1272

(3021601) Nitrite [Presence] in Urine by Test strip

1703

12716

1.71

47.92

7.4

5.3

0.00

estimate

0.35

511

2371

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

831

5060

1.86

47.66

1.3

1.2

2.57

1.57

u/ml

0.77

210

1275

(3011412) CD3 cells [#/volume] in Blood

103

211

5.01

47.43

2.5

2.0

1.19

1.13

e9/l

0.25

192

(3004616) Nuclear Ab [Presence] in Serum

126

306

4.24

47.03

1.5

1.2

—

(3021788) Differential panel - Synovial fluid

163

476

3.55

46.90

1.6

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

10.79

46.21

3.7

2.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

206

708

3.04

45.45

1.7

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1179

8065

1.72

44.99

4.1

3.2

1934.30

336.48

mg/l

7.60

853

5074

(40768797) Stomach Pathology biopsy report

633

3586

1.95

44.98

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

586

3234

1.99

44.92

7.3

6.6

11.26

12.06

kpa

3.36

555

3071

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

586

3235

1.99

44.88

7.4

6.6

5.06

5.09

kpa

0.35

556

3069

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

598

3332

1.97

44.56

2.3

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1952

15297

1.68

44.26

4.6

3.1

70.54

50.77

u/l

9.74

1811

13932

(3004809) Band form neutrophils/100 leukocytes in Blood

156

462

3.50

43.92

3.2

3.5

0.98

1.51

1.62

143

401

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

343

3.91

43.36

1.9

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

593

3323

1.96

43.36

2.3

1.8

—

(3003396) Base excess in Arterial blood by calculation

579

3227

1.97

42.97

7.4

6.6

1.34

1.19

mmol/l

0.35

454

2528

(1616796) Gas panel - Central venous blood

190

647

3.06

42.58

5.4

3.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

134

5.86

42.39

1.6

1.4

6.12

7.20

u/l

0.36

114

(40761536) Microorganisms panel - Urine sediment

442

2248

2.12

42.19

6.6

4.2

—

(3042631) Mycobacterium sp identified in Specimen

141

402

3.62

42.04

2.9

2.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

251

1001

2.63

41.86

2.0

2.1

244.34

727.95

ug/l

1.60

233

938

(3023420) DNA double strand Ab [Units/volume] in Serum

102

234

4.47

40.97

1.8

1.2

21.40

29.30

iu/ml

—

(3026008) Bacteria identified in Urine by Culture

1298

9284

1.66

40.82

4.5

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1213

8527

1.67

40.79

4.8

3.8

25.14

9.04

mg/mmol

8.32

839

5298

(21491868) Cryoglobulin [Mass/volume] in Serum

6.89

40.72

1.4

1.2

1.80

0.34

g/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

105

249

4.32

40.43

1.2

1.1

—

(3019060) Gas panel - Arterial blood

388

1907

2.17

40.35

4.8

4.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

155

5.33

40.30

2.3

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

150

461

3.36

39.84

3.2

3.0

—

(3012544) pH of Venous blood

502

2728

1.99

39.84

5.9

3.3

7.36

7.40

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

157

5.26

39.73

2.2

2.0

14.61

15.80

0.36

150

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

122

328

3.82

39.63

1.6

1.5

61.54

63.12

0.16

209

(1175426) CD3 cells/100 lymphocytes in Blood

162

5.17

39.37

2.3

2.0

73.78

70.95

0.76

150

(3009508) Creatinine [Moles/volume] in Urine

1183

8340

1.66

38.87

3.9

3.1

6.53

7.06

mmol/l

4.20

1019

6912

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

6.44

38.85

1.1

—

(3002032) Base excess in Venous blood by calculation

486

2634

1.99

38.79

5.9

3.4

1.71

2.03

mmol/l

1.08

417

2176

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

9.69

38.61

1.5

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

487

2648

1.99

38.50

5.9

3.3

5.83

kpa

0.03

476

2562

(3041096) Erythrocytes [Presence] in Urine by Automated

991

6689

1.69

38.38

5.4

3.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

939

6251

1.70

38.28

2.0

1.7

8820194.61

24990578.14

pmol/l

0.87

771

5074

(3016502) Oxygen saturation in Arterial blood

516

2868

1.95

38.25

7.7

7.0

94.92

95.36

0.73

495

2762

(40767503) Oxygen content in Capillary blood by calculation

179

630

2.95

37.81

4.1

2.5

14.77

15.97

4.08

106

319

(3038026) Centromere Ab [Units/volume] in Serum

216

4.45

37.69

1.3

1.1

28.78

52.27

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

143

5.34

37.47

2.6

1.9

558.91

484.40

e6/l

0.39

122

(3010838) Calcium [Moles/time] in 24 hour Urine

144

450

3.30

37.24

1.5

1.9

4.12

4.80

mmol/24h

1.75

125

373

(3005322) IgE [Units/volume] in Serum or Plasma

290

1311

2.33

36.80

1.4

1.3

302.64

215.72

u/ml

0.99

272

1199

(3012501) Base excess in Blood by calculation

181

652

2.88

36.65

5.8

4.7

2.50

2.79

mmol/l

0.73

135

458

(3018677) aPTT in Platelet poor plasma by Coagulation assay

692

4292

1.78

35.99

2.5

1.9

30.87

29.91

2.67

670

4149

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1445

10860

1.59

35.66

5.7

4.0

57.79

98.07

ng/l

0.50

1158

8060

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

135

5.35

35.59

2.7

1.9

0.21

e9/l

0.09

121

(3000475) Leukocytes [#/volume] in Synovial fluid

179

653

2.84

35.41

2.1

1.6

10865.10

14983.04

e6/l

0.96

132

467

(3021901) Oxygen saturation in Capillary blood

161

554

3.00

35.39

3.9

2.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

123

360

3.51

35.26

1.3

1.2

—

(3008898) HLA-B27 [Presence]

172

616

2.89

35.20

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

241

4.12

35.15

1.6

1.5

30.60

29.86

0.07

152

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

225

4.23

34.91

2.0

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

164

4.85

34.87

1.2

230.00

164.55

titre

—

(3023183) Ammonium ion [Moles/volume] in Plasma

155

527

3.04

34.80

2.6

2.8

32.64

36.12

umol/l

0.72

135

471

(3023419) Bacteria identified in Sputum by Culture

134

418

3.30

34.75

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

156

533

3.02

34.72

1.8

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

209

4.35

34.72

1.3

1.1

51.29

49.82

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

518

2973

1.88

34.58

5.0

3.7

—

(3015736) pH of Urine

1363

10167

1.58

34.32

4.9

3.7

6.01

5.84

0.57

492

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

134

424

3.25

33.96

2.1

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

134

424

3.25

33.96

2.1

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

839

5586

1.68

33.41

2.0

1.6

1.65

1.39

mg/l

0.72

685

4282

(3010421) pH of Blood

193

760

2.64

32.92

5.8

4.4

7.43

7.42

0.78

183

686

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

108

304

3.64

32.84

2.0

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1301

9698

1.57

32.27

6.3

4.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

196

4.32

32.16

1.3

1.1

1.90

3.90

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

154

546

2.91

32.09

1.5

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

319

1593

2.11

31.55

2.4

29.09

24.37

au/ml

0.19

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

492

2859

1.85

31.36

2.7

2.6

6.95

8.71

umol/l

1.80

402

2490

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

170

4.49

30.62

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

4.49

30.62

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

170

4.49

30.62

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

985

6951

1.60

30.56

6.7

4.3

0.00

estimate

1.08

478

2283

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

151

4.72

30.37

1.6

1.5

5.17

5.87

u/l

0.16

120

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

168

4.48

30.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

168

4.48

30.16

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

168

4.48

30.16

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

4.41

29.96

2.0

1.4

—

(40758558) Short blood count panel - Blood

927

6488

1.60

29.60

9.0

6.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

10.76

29.56

1.6

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

454

2620

1.85

29.47

8.6

7.3

112.63

119.95

g/l

12.96

443

2551

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

458

2662

1.84

29.03

4.3

2.9

291.87

231.81

ng/l

1.72

427

2427

(3012565) Volume of 24 hour Urine

122

5.08

28.92

3.4

2.6

2013.55

1872.50

0.45

102

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

273

3.55

28.03

1.9

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

147

4.56

27.56

2.1

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

147

4.56

27.56

2.1

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

291

3.44

27.51

3.3

3.4

58.52

57.53

0.16

242

(3022313) Gas panel - Capillary blood

268

1321

2.12

27.33

5.4

3.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

140

4.64

27.32

1.4

1.2

124.37

80.40

u/l

1.44

120

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

137

4.67

27.09

3.0

2.5

43.95

40.54

0.64

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

284

1437

2.07

27.02

1.3

62.67

52.36

au/ml

0.24

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

207

924

2.32

26.92

1.4

1.2

—

(3000991) Gas panel - Venous blood

397

2264

1.86

26.62

10.2

7.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

139

519

2.75

26.32

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

151

595

2.61

25.72

1.6

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

326

1781

1.92

24.89

7.3

6.5

24.44

24.58

mmol/l

0.26

313

1696

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

135

4.51

24.76

1.4

1.2

26.24

18.02

u/l

0.95

114

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

358

3.06

24.73

6.7

6.5

12.39

12.15

mg/l

0.19

102

332

(3044941) Cell count panel - Synovial fluid

121

434

2.86

24.71

1.7

1.4

—

(40768446) Kidney Pathology biopsy report

5.85

24.45

1.7

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

781

5458

1.57

24.30

3.2

3.1

2.49

2.46

mmol/l

9.26

685

4741

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2246

19442

1.50

23.99

4.9

4.1

15.07

14.98

pmol/l

0.94

2057

17301

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

257

3.41

23.93

2.0

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1533

12332

1.46

23.93

3.8

2.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

9.41

23.53

1.1

1.5

12.54

329171.93

nmol/l

0.48

(3014111) Lactate [Moles/volume] in Serum or Plasma

409

2444

1.77

23.36

7.8

6.2

1.41

1.38

mmol/l

0.20

398

2382

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

4.29

23.24

1.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

4.29

23.24

1.7

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

6.73

22.95

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

6.73

22.95

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

6.73

22.95

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

6.73

22.95

1.1

—

(3022145) Colonoscopy Study observation

452

2794

1.72

22.87

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

280

3.24

22.83

1.4

367.69

315.77

u/l

0.34

265

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

267

3.28

22.54

1.0

1.1

1.68

1.55

g/l

1.59

236

(3013512) EKG study

1101

8379

1.47

22.54

5.5

4.2

—

(3016750) Collection duration of Urine

150

4.12

22.48

2.1

2.0

500.64

495.09

min

0.14

117

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

191

3.72

22.34

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

234

3.43

22.31

2.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

234

3.43

22.31

2.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

234

3.43

22.31

2.0

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

156

668

2.40

22.29

3.2

2.3

4.18

3.63

g/l

3.12

144

632

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

280

3.20

22.17

1.9

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

280

3.20

22.17

1.9

1.5

—

(3019225) pH of Specimen

475

3018

1.67

21.61

7.5

4.4

—

(3047181) Lactate [Moles/volume] in Blood

187

880

2.19

21.42

7.0

5.7

1.42

1.31

mmol/l

0.68

172

781

(3003434) Protein [Mass/volume] in Pleural fluid

114

429

2.72

21.30

1.7

1.5

30.52

31.84

g/l

0.46

106

390

(21494814) CD8 cells/100 lymphocytes in Specimen

5.05

20.91

2.1

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

518

2.53

20.67

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

212

3.45

20.54

2.2

732.18

624.03

1.15

141

(3016650) Hepatitis A virus Ab [Presence] in Serum

310

2.99

20.43

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

364

2189

1.75

20.20

4.8

2.9

4.57

4.51

kpa

0.25

350

2112

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

146

3.96

19.91

4.3

3.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

5.48

19.77

2.3

1.9

29.48

27.63

0.28

(3006245) CD3-CD19+ cells/100 cells in Blood

5.40

19.47

2.3

1.9

9.16

11.00

0.35

(3019832) Treponema pallidum Ab [Presence] in Serum

248

1343

1.92

19.35

1.5

—

(3000494) Fungus identified in Specimen by Culture

457

2954

1.64

19.31

1.7

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

239

1281

1.93

19.23

2.7

1.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

297

1710

1.81

19.10

5.1

2.9

114.70

127.57

g/l

18.52

290

1665

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

218

3.31

18.99

1.4

1.3

12.06

13.48

u/l

0.24

201

(3044640) Blood type and Crossmatch panel - Blood

1100

8583

1.42

18.90

3.6

2.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

330

2.84

18.85

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

202

1030

2.02

18.75

3.7

2.7

0.33

0.34

u/ml

0.29

127

588

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

215

1126

1.97

18.50

6.1

4.0

24.89

24.86

mmol/l

0.05

201

1027

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

219

1155

1.96

18.47

6.5

4.9

1.74

1.61

1.23

206

1087

(3017732) Neutrophils [#/volume] in Blood

299

1747

1.78

18.29

4.0

3.2

8.69

5.01

e9/l

0.79

218

1332

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

3.02

18.14

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2748

25280

1.54

17.93

35.7

15.9

27.54

25.49

mg/l

3.13

2611

20390

(3014576) Chloride [Moles/volume] in Serum or Plasma

511

3451

1.57

17.89

8.3

6.3

103.61

104.26

mmol/l

1.91

511

3446

(3000570) Elastase.pancreatic [Mass/mass] in Stool

164

788

2.14

17.84

1.4

1.5

273.37

272.87

ug/g

0.01

462

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

260

1468

1.84

17.80

9.1

8.5

24.46

24.37

mmol/l

0.17

242

1411

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

307

2.85

17.79

1.3

378.96

305.37

pmol/l

0.75

266

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

408

2618

1.64

17.67

3.0

2.4

6.54

6.42

ug/l

0.04

350

2218

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

254

1427

1.85

17.67

2.7

3.2

4.21

4.42

pmol/l

2.56

220

1248

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

258

1463

1.83

17.41

10.9

9.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

744

5469

1.47

17.36

5.6

3.9

199.85

353.78

ng/l

1.99

634

4550

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

190

3.36

17.36

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

328

2.76

17.36

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

324

2.76

17.20

3.3

3.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

280

2.90

17.17

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

359

2.67

17.12

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

872

6622

1.43

17.06

5.3

3.8

86.93

87.19

0.10

847

6444

(3036782) Glucose [Moles/volume] in Pleural fluid

298

2.83

17.00

1.5

1.4

7.08

6.63

mmol/l

0.54

282

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

193

3.31

16.94

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

3.52

16.89

2.1

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

165

3.50

16.74

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

141

657

2.20

16.58

3.6

2.2

119.69

127.83

g/l

4.11

115

480

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

216

1176

1.90

16.57

2.4

1.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

196

3.26

16.54

3.0

2.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.12

16.46

2.9

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

282

2.85

16.37

3.7

3.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

439

2.46

16.35

1.3

1.2

93.87

46.62

u/l

1.00

375

(3003181) Sodium [Moles/volume] in Urine

122

539

2.31

16.30

1.5

1.3

56.84

63.06

mmol/l

1.20

432

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

369

2.59

16.22

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

127

3.82

16.08

1.4

2.60

4.33

—

(3011985) Renin [Units/volume] in Plasma

330

2.68

16.08

1.7

1.4

85.86

52.43

mu/l

0.63

293

(3036071) Salmonella sp Ab [Titer] in Serum

5.29

16.07

1.2

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

209

1146

1.88

15.69

6.7

5.0

0.89

0.88

0.01

196

1080

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

139

3.64

15.61

1.1

—

titre

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

262

1548

1.75

15.38

2.6

2.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

628

4567

1.46

15.26

3.6

2.8

1.40

1.26

e6/l

0.30

406

2619

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

136

650

2.14

15.03

2.5

2.2

216.41

97.50

ug/min

1.29

394

(3039000) Anion gap in Blood

129

604

2.18

15.01

8.0

6.8

11.61

11.13

mmol/l

0.83

119

542

(3018572) Chloride [Moles/volume] in Blood

129

605

2.18

14.95

8.0

6.8

104.21

105.18

mmol/l

1.34

119

543

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

447

3043

1.54

14.93

2.7

3.9

9.16

20.03

ug/l

1.56

363

2487

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

284

1736

1.70

14.75

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.89

14.73

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

232

2.93

14.70

1.2

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

300

2.67

14.60

1.5

1.2

7.83

3.53

u/ml

0.97

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

337

2168

1.62

14.34

1.8

1.7

1.70

1.51

4.02

276

1848

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

362

2.50

14.31

1.7

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.51

14.23

2.1

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

111

3.82

14.12

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

111

3.82

14.12

1.1

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

4.02

14.05

1.2

1.1

38.60

11.58

u/ml

—

(3025941) Bacteria identified in Stool by Culture

229

1336

1.77

14.04

1.4

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.81

14.00

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

342

2.53

13.99

1.4

1.3

0.22

0.28

nmol/l

—

(36660697) Celiac disease serology panel - Serum

288

1798

1.66

13.80

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

357

2.48

13.74

1.7

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

388

2.41

13.70

1.8

1.4

2972.63

1867.44

e6/l

0.33

290

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

584

4268

1.45

13.68

3.8

2.9

3.60

2.64

e6/l

1.04

356

2333

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

224

1309

1.76

13.66

7.1

3.6

23.97

24.16

mmol/l

0.38

218

1275

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.51

13.64

1.1

19.41

24.09

u/l

0.30

(3006922) Hepatitis E virus Ab [Presence] in Serum

114

3.72

13.61

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

353

2.48

13.58

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

354

2.47

13.50

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

355

2.46

13.42

1.7

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

145

3.34

13.26

2.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

145

3.34

13.26

2.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

359

2.43

13.11

1.7

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.65

13.05

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

239

1441

1.71

13.05

1.2

109.57

151.31

iu/ml

1.16

514

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

204

2.93

13.02

2.7

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

2.44

12.94

1.8

1.4

105510.13

80053.22

e6/l

0.24

211

(40768806) Pleura Pathology biopsy report

337

2.47

12.93

1.8

1.6

—

(3035880) pH of Pleural fluid

184

3.02

12.86

1.4

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

314

2.52

12.85

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2539

23396

1.38

12.83

6.1

4.9

2.00

2.04

mu/l

0.26

2353

20996

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.35

12.76

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

304

2.54

12.69

1.4

1.3

—

nmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.13

12.68

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

5.37

12.29

6.7

4.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

256

2.65

12.28

1.7

1.3

30393.32

116919.41

e6/l

0.96

174

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

292

2.53

12.21

1.5

1.2

7.18

4.92

u/ml

0.43

126

(3014148) Varicella zoster virus Ab [Titer] in Serum

190

2.93

12.18

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.98

12.17

1.4

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.49

12.12

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

134

691

1.98

12.12

1.9

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

192

2.90

11.96

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

833

6599

1.35

11.92

3.6

2.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

213

1280

1.71

11.78

4.2

2.4

0.68

0.64

0.96

213

1272

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

109

528

2.10

11.70

1.3

1.5

19739.48

899.11

e6/l

0.50

440

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

109

528

2.10

11.70

1.2

1.4

83.04

27.69

e6/l

0.79

417

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

174

2.96

11.56

1.1

1.0

—

(40768441) Liver Pathology biopsy report

148

3.14

11.52

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

134

3.24

11.35

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

134

3.24

11.35

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

215

2.73

11.30

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.23

11.26

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

120

3.36

11.22

1.1

1.10

1.05

ratio

1.16

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

214

1308

1.68

11.12

4.2

2.4

1.17

1.12

0.35

214

1298

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.72

11.11

1.1

2.8

68.04

67.70

mg/l

0.01

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.57

11.01

4.9

4.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

11.94

10.82

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1536

13393

1.28

10.49

2.9

2.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.08

10.41

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

175

2.83

10.27

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

221

2.61

10.21

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.62

10.08

2.0

214.60

31976.07

u/ml

—

(40768443) Skin Pathology biopsy report

192

1173

1.68

10.01

1.2

—

(3020891) Body temperature

189

1162

1.66

9.63

5.2

4.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

3.00

9.57

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.02

9.56

2.0

1.6

108.50

125.25

ng/l

0.22

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

235

2.49

9.52

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

119

3.13

9.33

1.1

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

130

3.02

9.26

1.2

1.5

58.46

66.86

0.73

105

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

141

2.93

9.23

1.2

—

(4035726) Immunohistochemistry procedure

337

2385

1.46

9.18

1.4

—

(3024928) Oxygen saturation in Venous blood

106

559

1.93

9.06

5.0

2.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.05

9.01

1.2

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

436

2.05

8.98

1.3

11.93

11.62

u/l

0.06

352

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

7.45

8.91

1.8

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

117

641

1.86

8.91

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

117

641

1.86

8.91

1.5

1.3

—

(3024471) HLA-A [Type]

4.34

8.86

1.0

—

(40768795) Lymph node Pathology biopsy report

239

2.41

8.73

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

197

2.56

8.72

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

283

2.29

8.69

1.8

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

348

2.15

8.66

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

3.20

8.62

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

480

1.96

8.49

1.1

1.4

—

(3024932) HLA-DR beta [Type]

4.31

8.39

1.1

—

(3004451) EKG impression Narrative

150

2.76

8.28

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

112

3.06

8.27

2.8

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

233

2.38

8.25

1.0

1.1

—

3.18

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

108

595

1.84

8.12

2.4

3.2

276.85

821.73

u/ml

0.56

543

(3000060) B lymphocytes [#/volume] in Blood

4.54

8.11

2.2

1.9

245.00

177.50

e6/l

—

(3045788) Cell count panel - Pleural fluid

305

2.19

8.10

1.9

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

159

982

1.65

8.00

2.5

3.2

1258.31

4430.11

u/ml

0.52

130

824

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.53

7.96

1.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.28

7.93

1.8

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

2.88

7.90

1.0

1.1

1.09

1.17

u/l

0.28

(3045424) Erythrocytes [Presence] in Urine

416

2.00

7.89

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

2.82

7.84

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

107

595

1.83

7.82

1.1

25.06

8.25

u/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

330

2401

1.42

7.73

3.2

2.3

30.93

37.15

u/l

1.81

284

2033

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.88

7.69

1.3

1.2

1.08

1.70

mmol/l

1.49

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

2.97

7.65

2.8

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

2.97

7.65

2.8

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.81

7.52

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

117

677

1.76

7.50

2.9

2.1

92.69

89.77

0.58

112

648

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

109

620

1.78

7.41

3.5

2.3

214.11

197.08

0.93

104

584

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.44

7.39

1.4

1.6

113.64

170.74

nmol/24h

0.27

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

260

1836

1.45

7.17

2.0

1.7

—

(3016135) IgD [Mass/volume] in Serum

20.05

7.13

1.1

1.4

28.77

153.86

mg/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.03

7.06

14.7

12.1

4.73

6.13

mmol/l

1.14

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2486

23416

1.26

7.03

7.9

6.1

42.45

40.40

mmol/mol

17.14

2291

21252

(3035320) C reactive protein [Mass/volume] in Body fluid

176

2.46

7.00

3.6

2.5

—

(3008295) Osmolality of Serum or Plasma

297

2.11

7.00

1.4

1.3

277.91

276.44

mosm/kgh2o

0.18

218

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.16

6.98

1.1

1.3

724.59

428.35

ug/l

0.15

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.40

6.96

1.5

1.6

—

2024630.00

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

201

2.36

6.96

1.2

—

(40761535) Cells panel - Urine sediment

320

2360

1.39

6.93

5.7

3.5

—

(3002385) Erythrocyte distribution width [Ratio]

2268

21162

1.23

6.91

36.3

18.6

15.59

15.27

2.15

2235

20710

(3021387) Prolactin [Units/volume] in Serum or Plasma

524

1.82

6.86

2.0

1.6

320.35

312.39

mu/l

0.08

471

(3017569) Oxygen content in Arterial blood

139

2.61

6.62

2.3

2.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.82

6.53

1.4

1.2

0.61

2.08

mmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

135

2.61

6.45

2.5

3.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.32

6.45

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

104

609

1.73

6.45

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

113

2.76

6.37

1.1

1.4

64.75

68.50

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

733

6144

1.25

6.25

5.6

3.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

304

2.03

6.24

1.1

—

11.43

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

571

1.74

6.20

2.0

1.8

2.78

4.76

iu/l

3.12

188

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.12

6.08

1.4

1.2

18.00

953.92

u/l

—

(3016018) Differential panel - Cerebral spinal fluid

240

2.14

6.07

1.2

1.4

—

(4200892) Spirometry reversibility

248

1794

1.41

6.03

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

123

768

1.63

6.01

3.6

3.2

0.82

0.81

nmol/l

0.05

586

(3034426) Prothrombin time (PT)

3.46

6.00

1.5

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

283

2096

1.38

5.99

3.2

2.7

49.91

61.82

ml/min/173m2

7.29

162

907

(3049717) Cytology report of Urine Cyto stain

168

1130

1.51

5.95

2.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.86

5.93

1.7

1.8

56.36

57.16

ug/l

0.02

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.05

5.91

1.4

1.6

16.36

14.69

pmol/l

0.56

(40765096) Chromosome analysis panel by Banding

2.90

5.88

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

160

2.39

5.87

1.3

0.77

1.34

u/ml

0.28

(3019977) pH of Arterial blood

154

2.42

5.86

2.3

2.5

7.42

7.43

0.10

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

148

2.45

5.86

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

167

2.35

5.81

1.1

48.01

41.56

mg/l

0.46

143

(3036489) Thrombin time

136

878

1.57

5.80

2.7

1.9

21.67

21.45

0.18

120

780

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

2.50

5.77

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

669

5607

1.24

5.66

6.4

4.4

1.02

kg/l

0.41

113

877

(3028433) Virus identified in Specimen by Culture

2.89

5.61

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.74

5.60

1.1

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.54

5.60

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

104

2.71

5.59

1.2

1.5

1.30

2.47

0.67

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.94

5.57

1.4

43.29

28.92

0.86

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

2.65

5.56

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

354

1.88

5.51

1.7

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.78

5.46

1.2

1.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.82

5.40

2.7

4.2

57.88

55.90

0.16

(3024263) Appearance of Synovial fluid

148

2.38

5.38

1.6

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

6.21

5.38

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

260

2.02

5.32

1.1

1.0

4.06

2.11

u/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.41

5.30

1.2

1.1

—

(3018133) Calcium [Moles/volume] in Urine

5.02

5.24

2.3

2.0

2.15

2.71

mmol/l

0.50

(3036670) Protein [Mass/volume] in Synovial fluid

2.76

5.20

1.8

1.2

37.23

38.86

g/l

0.20

(3019550) Sodium [Moles/volume] in Serum or Plasma

2750

26435

1.25

5.19

35.6

18.7

138.94

139.60

mmol/l

30.33

2696

25656

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.67

5.07

2.8

2.6

72.07

149.31

umol/l

1.09

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.41

5.02

6.1

7.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.41

5.02

1.9

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

160

2.26

4.98

1.0

1.1

228.31

295.99

mg/l

1.70

138

(3009871) Measles virus Ab [Titer] in Serum

3.23

4.89

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

168

2.22

4.87

1.9

1.5

—

(40758292) HTLV I+II Ab panel - Serum

4.56

4.86

1.9

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

119

2.45

4.79

1.3

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2750

26490

1.24

4.75

36.2

18.8

4.01

3.99

mmol/l

5.89

2692

25665

(3009015) Lactate [Moles/volume] in Synovial fluid

4.43

4.74

1.6

1.3

5.36

5.79

mmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

139

2.32

4.68

2.1

1.8

3.17

2.59

u/field

0.24

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

2.36

4.57

1.2

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

8.20

4.56

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1429

0.63

4.52

1.8

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

968

0.56

4.45

1.5

1.4

—

(3000492) Spirometry study

269

2077

1.32

4.39

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

1165

10498

1.17

4.35

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

123

831

1.50

4.35

4.6

3.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

245

1.93

4.34

2.4

2.1

1.33

2.14

u/field

0.67

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.21

4.33

1.2

1.6

5.00

5.04

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

4.32

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

101

2.49

4.29

1.0

1.1

21.40

370.42

ng/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.27

4.29

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.27

4.29

1.0

—

(3045414) Leukocytes [Presence] in Urine

164

1175

1.42

4.28

1.9

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

11.69

4.27

1.1

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

184

1346

1.39

4.26

2.6

3.7

60.99

72.38

u/ml

0.28

178

1296

(3044889) 12 lead EKG panel

1930

18095

1.16

4.24

5.4

4.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.05

4.23

2.7

2.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.90

4.12

1.1

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.35

4.12

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

102

673

1.53

4.06

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

129

2.26

4.05

1.1

1.3

1.23

1.14

nmol/l

0.21

100

(21494755) Public health laboratory ask at order entry panel

1236

0.63

4.04

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.34

4.04

5.6

7.4

—

(3029075) Extractable nuclear Ab panel - Serum

2.76

4.01

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

10.02

4.01

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.68

3.99

1.1

1445.40

1724.97

miu/ml

0.57

(3002079) Sodium [Moles/time] in 24 hour Urine

105

2.39

3.97

1.1

1.2

155.00

154.20

mmol/24h

0.01

105

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

2.37

3.90

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

262

1.84

3.90

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

292

1.79

3.86

4.0

2.8

—

(3014891) Appearance of Pleural fluid

3.07

3.80

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2748

26599

1.21

3.78

19.4

10.7

24.12

24.49

u/l

0.43

2680

25380

(3052592) Norovirus Ag [Presence] in Stool

2.70

3.65

1.2

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.61

3.63

1.3

1.4

11.73

13.44

g/l

0.34

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

390

3231

1.24

3.63

1.4

—

(40757373) Influenza virus identified in Isolate

2.58

3.54

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.51

3.54

1.1

1.2

—

(4212803) Bone marrow aspirate examination

4.24

3.50

1.4

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.24

3.50

1.8

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

287

1.75

3.48

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.48

3.46

3.6

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

159

2.02

3.44

1.7

1.3

1.14

1.10

promille

0.05

119

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

858

1.43

3.42

1.5

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.01

3.37

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

7.01

3.36

1.6

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

101

2.29

3.35

5.6

4.9

46.00

59.60

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.73

3.34

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

748

6627

1.17

3.33

1.7

1.6

1.43

1.33

mmol/l

2.41

592

5481

(3023410) Appearance of Cerebral spinal fluid

232

1.82

3.33

1.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.36

3.30

7.7

4.0

—

(3019174) dRVVT (LA screen)

4.36

3.30

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

4.36

3.30

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

486

1.56

3.30

1.3

1.2

111.88

222.18

miu/ml

1.92

207

(40761511) CBC panel - Blood by Automated count

2674

25896

1.18

3.26

30.6

15.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

156

2.00

3.24

2.5

2.0

—

18.49

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.18

3.19

1.2

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.37

3.18

1.7

4.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.80

3.18

4.6

7.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.25

3.12

2.8

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

640

1.47

3.10

1.4

1.3

29.81

30.65

iu/l

0.09

538

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.23

3.05

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.01

3.05

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

734

6536

1.16

3.04

1.5

1.4

—

(3003338) MCHC [Mass/volume]

1931

20282

0.88

3.04

40.7

20.8

327.19

331.26

g/l

65.64

1909

20063

(3020650) Glucose [Presence] in Urine

2.64

2.96

1.5

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.68

2.86

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

122

2.06

2.86

1.2

1.1

11.14

9.40

iu/ml

—

(3051593) INR in Capillary blood by Coagulation assay

164

1.90

2.85

15.6

15.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

208

1.79

2.82

1.0

1.46

0.96

u/ml

0.31

105

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

746

1.41

2.81

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

2.81

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.40

2.80

1.2

40.14

11.58

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

8.34

2.75

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

8.34

2.75

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

8.34

2.75

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

278

1.66

2.74

1.0

1.1

5.56

1.44

u/ml

0.80

138

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.21

2.73

1.2

2.5

169.80

165.71

0.06

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.51

2.70

1.7

1.0

231.78

270.95

pmol/l

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

6.01

2.70

2.0

1.8

1.50

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.22

2.67

2.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

374

1.56

2.67

3.1

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

102

739

1.39

2.63

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

103

752

1.38

2.54

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

297

3525

0.83

2.53

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

2.04

2.51

1.5

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

224

1.70

2.50

1.4

1.3

24.63

30.06

u/l

0.49

183

(3020393) Adenovirus Ag [Presence] in Stool

3.47

2.48

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

220

0.41

2.42

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.35

2.38

1.2

1.3

99.40

119.85

nmol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

6.26

2.37

1.0

318.60

272.50

nmol/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.26

2.37

1.2

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.12

2.36

1.0

5.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

468

1.46

2.35

2.8

1.5

0.94

0.78

nmol/l

1.23

379

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.26

2.34

1.0

1.1

89.22

85.54

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

1.77

2.34

1.0

9.65

3.18

u/ml

0.79

(3016038) Potassium [Moles/volume] in Urine

199

1.72

2.31

1.3

1.1

22.45

34.13

mmol/l

3.77

172

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.31

1.2

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

238

1.65

2.28

1.0

1.1

0.44

1.31

u/ml

0.83

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.62

2.27

5.2

3.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.11

2.22

2.0

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.51

2.18

2.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

404

1.47

2.12

2.7

2.2

23.83

22.47

mg/l

0.08

(3003888) Timothy IgE Ab [Units/volume] in Serum

244

1.61

2.10

1.0

4.91

4.29

u/ml

0.07

105

(3044242) Glucose [Moles/volume] in Arterial blood

153

1.77

2.07

2.5

2.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.08

2.06

1.8

1.3

32.33

24.99

0.33

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.41

2.02

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.08

2.01

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.23

2.00

1.5

11.28

9.05

ug/l

1.05

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.96

2.00

4.1

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.82

2.00

2.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.82

2.00

1.9

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.15

1.98

1.7

2.0

—

(3006270) Folate [Moles/volume] in Blood

264

1.56

1.97

1.0

1.2

298.00

342.41

nmol/l

0.70

224

(4146454) Self-monitoring of blood glucose

322

1.50

1.93

2.8

2.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

347

1.48

1.92

1.6

—

(3006462) Nitrate [Presence] in Urine

135

1.78

1.91

5.7

4.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2433

23656

1.11

1.90

28.3

15.1

71.26

75.37

ml/min/173m2

13.30

2182

19540

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.86

1.86

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.86

1.86

1.9

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.86

1.86

1.1

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2520

24570

1.11

1.80

5.7

4.9

6.20

6.01

mmol/l

7.97

2281

21867

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.05

1.80

1.1

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

161

1.68

1.78

1.0

1.1

13.82

4.27

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2391

23256

1.10

1.77

4.5

4.1

1.38

1.27

mmol/l

9.42

2151

20701

(3006653) Thiamine [Moles/volume] in Blood

117

1.80

1.74

1.2

1.1

153.71

136.64

nmol/l

0.82

117

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.23

1.73

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

194

1.60

1.71

3.4

3.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

200

1688

1.20

1.66

1.2

1.3

—

(3020491) Glucose [Moles/volume] in Blood

196

1.59

1.65

2.1

2.8

8.66

6.93

mmol/l

1.32

129

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

220

1.55

1.65

1.2

1.3

1.41

1.51

nmol/l

0.15

196

(3002256) Pathology report gross observation

387

3443

1.14

1.64

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.03

1.64

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.03

1.64

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.93

1.64

2.2

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.38

1.61

1.9

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

270

1.49

1.61

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.00

1.59

1.0

1.3

91.44

83.70

—

(40768800) Prostate Pathology biopsy report

337

1.43

1.59

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.70

1.58

1.1

1.3

—

640.53

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

346

1.42

1.57

3.6

4.6

343.58

346.55

umol/l

0.06

296

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.04

1.54

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.86

1.50

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

158

1320

1.21

1.49

1.7

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.00

1.48

1.2

2.7

170.38

171.21

0.01

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

411

4556

0.89

1.48

3.2

3.1

0.71

0.74

ug/l

0.37

297

3199

(3000034) Microalbumin [Mass/volume] in Urine

236

1.49

1.44

3.6

3.0

180.02

23.11

mg/l

0.70

178

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.31

1.43

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

793

1.26

1.40

4.7

4.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.42

1.39

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.94

1.38

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

348

1.38

1.36

1.1

12.00

51.06

iu/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.94

1.36

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

112

1.70

1.35

1.1

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

120

1.67

1.34

1.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.15

1.33

2.0

2.3

—

(3022689) Creatine [Moles/volume] in Urine

1.97

1.32

1.2

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

1.30

1.7

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

1.30

1.7

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

1.30

1.7

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

327

1.38

1.28

1.2

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2482

24317

1.09

1.24

5.0

4.6

4.40

4.56

mmol/l

12.09

2266

22041

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.40

1.24

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.63

1.21

1.4

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.63

1.21

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

151

1285

1.18

1.21

2.2

10.15

12.39

nmol/l

2.38

128

1114

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.00

1.16

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

2.00

1.16

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

154

0.52

1.13

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

191

1.47

1.13

1.9

1.8

6.27

11.03

umol/l

0.73

125

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

151

1.53

1.11

1.0

0.12

0.20

u/ml

—

(3051651) Icteric interference index of Serum or Plasma

161

1.49

1.06

3.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

453

1.29

1.06

2.3

2.0

5993.69

3755.65

u/l

0.16

189

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2454

24091

1.07

1.03

4.9

4.5

1.39

1.48

mmol/l

17.63

2224

21675

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

154

1.50

1.03

2.6

2.4

—

(3005570) Glucose [Moles/volume] in Urine

289

1.35

1.03

2.8

2.1

—

(3036180) Methadone [Presence] in Urine

1.92

1.02

1.4

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

239

1.38

1.00

1.5

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

855

8118

1.07

1.00

5.0

4.9

4.35

3.62

ug/l

0.18

738

7118

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.98

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

166

1455

1.15

0.96

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

1.80

0.96

5.0

5.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.74

0.96

1.3

—

(3015183) Erythrocyte sedimentation rate

1.69

0.95

1.6

1.2

—

(3000330) Specific gravity of Urine by Test strip

170

1496

1.14

0.94

4.2

3.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.22

0.93

1.2

2.1

11.03

18.35

umol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

381

3516

1.09

0.91

4.7

32.76

33.30

0.38

286

2291

(3000285) Sodium [Moles/volume] in Blood

1.86

0.87

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

322

0.71

0.86

1.7

—

(3010813) Leukocytes [#/volume] in Blood

2792

27593

1.08

0.86

47.5

23.3

7.49

6.83

e9/l

40.32

2734

26613

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2789

27576

1.08

0.81

47.5

23.4

37.08

39.31

56.87

2552

25464

(3002619) Bacteria identified in Specimen by Culture

1.70

0.80

1.4

1.1

—

(3025577) Chromium [Mass/volume] in Blood

181

1.38

0.79

2.1

1.43

2.07

ug/l

1.42

157

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

164

1.41

0.79

2.0

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.82

0.79

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

2789

27584

1.08

0.78

47.5

23.3

266.64

246.68

e9/l

33.54

2736

26726

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2531

24960

1.06

0.75

5.5

5.1

2.53

2.65

mmol/l

9.11

2307

22495

(3024731) MCV [Entitic volume]

2789

27591

1.07

0.75

47.4

23.3

92.01

91.48

5.86

2741

27037

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

192

1.36

0.75

1.4

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

264

2423

1.10

0.75

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.60

0.74

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.60

0.74

1.0

1.1

—

(3035941) MCH [Entitic mass]

2789

27593

1.07

0.74

47.3

23.2

30.15

30.35

5.85

2740

27039

(3026361) Erythrocytes [#/volume] in Blood

2789

27594

1.07

0.74

47.5

23.3

4.13

4.40

e12/l

123.41

2724

26616

(3000963) Hemoglobin [Mass/volume] in Blood

2789

27601

1.07

0.72

47.9

23.5

123.05

132.68

g/l

187.11

2740

27053

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

1.32

0.70

3.7

5.1

27.63

43.92

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.44

0.69

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.85

0.68

5.6

2.6

0.00

0.89

u/field

—

(3014051) Protein [Presence] in Urine by Test strip

745

1.16

0.65

3.2

2.7

—

(4034850) Laboratory test

850

0.86

0.64

20.6

11.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

1.35

0.64

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

534

0.82

0.62

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

298

1.24

0.60

3.9

3.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

356

0.78

0.60

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.72

0.57

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.67

0.56

3.2

2.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.56

1.8

1.4

35.50

40.94

umol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

848

0.87

0.55

1.4

1.8

—

(3011648) Oxygen content in Venous blood

203

1.28

0.55

2.3

2.0

10.80

10.98

0.08

203

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.0

1.2

—

(1002224) Polysomnography panel

698

0.86

0.55

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.42

0.54

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.54

0.53

1.7

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

651

0.86

0.52

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

171

1.29

0.49

1.8

1.6

98.18

86.04

umol/l

0.80

171

(3004716) Salmonella sp identified in Stool by Organism specific culture

121

1097

1.11

0.49

1.4

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

615

0.86

0.49

5.3

3.7

30.78

27.61

mg/l

0.30

393

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

129

1.32

0.45

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

138

1.31

0.45

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

154

1421

1.09

0.45

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

641

0.87

0.44

1.9

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.45

0.44

1.4

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.61

0.43

1.0

1.2

1.64

1.76

umol/24h

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.61

0.43

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.56

0.42

1.2

1.1

—

(3022621) pH of Urine by Test strip

198

1853

1.07

0.42

3.7

3.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

195

0.77

0.41

1.0

819.44

680.72

ng/l

—

116

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.43

0.39

1.8

1.1

—

(40768793) Breast Pathology biopsy report

642

0.89

0.37

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.29

0.36

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

773

1.10

0.36

1.8

—

(3011288) Drugs identified in Urine by Screen method

281

1.18

0.36

2.0

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

0.84

0.34

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

0.84

0.34

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

254

0.83

0.34

1.3

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

297

0.84

0.33

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

297

0.84

0.33

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

373

3590

1.04

0.32

14.4

7.7

—

(4281824) Cell count and differential, peritoneal fluid

294

1.16

0.32

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.33

0.32

2.3

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.33

0.32

2.3

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.29

0.31

1.5

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

229

0.83

0.30

1.8

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

250

0.84

0.30

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

250

1.16

0.29

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

316

1.14

0.29

1.9

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

106

0.75

0.29

1.1

1.5

106.29

160.47

pmol/l

—

106

(1001926) Buprenorphine [Presence] in Urine by Screen method

320

1.13

0.25

1.6

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

217

1.15

0.24

1.2

1.4

0.26

0.29

nmol/l

0.25

168

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

212

0.85

0.24

1.8

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

317

0.88

0.23

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

243

0.86

0.23

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

242

0.87

0.22

1.5

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

188

0.85

0.21

1.6

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.50

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

105

0.76

0.21

1.9

1.4

1.66

1.56

g/l

—

105

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

250

1.12

0.19

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

757

7456

1.02

0.18

3.4

3.1

—

(3027008) Opiates [Presence] in Urine

408

0.93

0.13

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

609

1.05

0.12

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

1124

1.03

0.11

1.1

1.0

—

(3028300) Cannabinoids [Presence] in Urine

410

0.95

0.08

1.7

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.77

0.08

1.0

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.86

0.07

1.3

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

0.89

0.07

1.0

—

(3025130) Human papilloma virus identified in Specimen

246

1.06

0.06

1.8

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

150

1.07

0.04

5.0

6.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

552

0.98

0.03

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

689

0.99

0.01

1.5

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

406

0.99

0.00

1.6

1.4

—

(3016879) Cocaine [Presence] in Urine

379

1.00

0.00

1.6

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

266

1.02

0.00

1.3

8.00

7.57

mmol/l

0.32

224

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

138

1.01

0.00

1.9

1.5

0.94

g/l

0.02

138

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

644

6438

1.00

0.00

4.5

4.2

21.89

22.80

0.78

314

3258

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

123

0.98

0.00

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

13.09

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.32

—

(3027944) Amphetamines [Presence] in Urine

400

1.00

-0.00

1.6

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.6

—

4.20

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.65

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.91

-0.00

2.1

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.98

-0.00

1.3

1.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

2.11

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.91

-0.00

1.0

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.38

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

362.60

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO – Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity (R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints